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Itsehoito on yleinen tapa hoitaa 
lasten lieviä oireita. Suomessa lasten 
itsehoidon yleisyyttä on viimeksi 
tutkittu vuonna 1995/96 osana laa-
jempaa väestötutkimusta suoma-
laisten terveydestä ja terveyspalve-
lujen käytöstä. Tämän tutkimuksen 
tavoitteena oli tutkia millainen on 
suomalaisten lasten terveydentila, 
kuinka yleistä itsehoidon käyttö on 
lapsilla ja mitkä tekijät niihin ovat 
yhteydessä. Tutkimuksen aineistona 
käytettiin vuonna 2007 toteutettua 
väestötutkimusta alle 12-vuotiaiden 
lasten lääkkeiden käytöstä.
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ABSTRACT 
 
In this thesis, children’s health, self-care process, the use of self-medication and factors associated with health, 
self-care and self-medication are described in the literature review. The empirical part of this thesis evaluates 
the health, the use of self-medication (including over-the-counter (OTC) medicines and complementary and 
alternative medicines (CAMs)) and factors associated with health and self-medication among Finnish children. 
This study is based on a cross-sectional questionnaire survey for parents of children under 12 years of age 
that was carried out in spring 2007. The study population consisted of a random sample of Finnish children 
(n=6,000) aged under 12 years. A questionnaire was sent primarily to mothers, and a response rate of 67% 
(n=4,032) was gained. 
The majority of children (97%) had good health status reported by their parent. One tenth of children had 
some long-term disease, mainly allergy or asthma, and over half (66%) of children had experienced some 
symptom(s) currently. Symptoms of common cold and eczema were the most common symptoms children 
had experienced. The prevalence of psychosomatic symptoms was 11%; sleep disorders and fatigue or 
dizziness were the most common among these.  
Half of the children had used some self-medication (including OTC medicines, vitamins and CAMs). One 
fifth (17%) of the children had used OTC medicines, and one tenth (11%) had used CAMs. Analgesics and 
antipyretics, mainly paracetamol, were the most common OTC medicines used among children, and fish oils 
and fatty acids, followed by probiotics, the most common CAMs.  
Parental socioeconomic background was not associated with health or the use of OTC medicines or CAMs, 
whereas parental attitudes toward medicines were especially associated with the use of CAMs. CAMs use was 
less likely among children whose parents had positive views toward prescription medicines. In addition, 
parental positive attitude toward OTC medicines, and on the other hand, worries about the risks of medicines 
predicted the use of CAMs among children. 
The health of Finnish children was mainly good, even though the experience of symptoms and the use of 
self-medication were quite common among them. Parental socioeconomic background was not associated 
with health or the use of self-medication among children. Instead, parental attitudes, such as worries about 
the risks of medicines were found to be associated with the use of self-medication among children, predicting 
especially the use of CAMs among them. Health care professionals should ensure the safe use of self-
medication among children administered by their parents, also taking into account parents’ views on the use 
of medicines. 
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TIIVISTELMÄ 
 
Tämän tutkimuksen kirjallisuuskatsauksessa käsitellään lasten terveydentilaa, itsehoidon prosessia lapsilla, 
itselääkityksen käyttöä sekä näihin yhteydessä olevia tekijöitä. Tutkimuksen tavoitteena on selvittää 
suomalaisten lasten terveydentilaa, lasten itselääkityksen, itsehoitolääkkeiden ja täydentävien ja 
vaihtoehtoisten valmisteiden käytön yleisyyttä sekä mitkä tekijät ovat yhteydessä suomalaisten lasten 
terveyteen ja itselääkitykseen. 
Kyselytutkimus toteutettiin keväällä 2007. Tutkimusjoukko muodostui 6000 suomalaisesta alle 12-
vuotiaasta lapsesta, jotka poimittiin satunnaisotannalla väestörekisterikeskuksen tietokannasta. Tutkimus 
tehtiin postikyselynä, joka lähetettiin lapsen vanhemmalle, ensisijaisesti lapsen äidille. Vastausprosentti oli 
67 % (n = 4032).  
Suurin osa vanhemmista (97 %) arvioi lapsensa terveydentilan olevan hyvä. Noin yhdellä kymmenestä 
lapsesta oli jokin pitkäaikaissairaus ja yli puolella (66 %) oli vähintään yksi oire tutkimukseen 
vastaamishetkellä. Flunssan oireet ja ihottuma olivat näistä yleisimmät. Psykosomaattisia oireita, yleisimmin 
unihäiriöita sekä väsymystä tai heikotusta, oli kokenut 11 % lapsista.  
Puolet lapsista oli käyttänyt jotain itselääkitystä (itsehoitolääkkeitä, vitamiineja ja/tai täydentäviä ja 
vaihtoehtoisia valmisteita). Viidesosa (17 %) lapsista oli käyttänyt jotain itsehoitolääkettä ja kymmenesosa (11 
%) jotain täydentävää ja vaihtoehtoista valmistetta. Kipu- ja kuumelääkkeet, yleisimmin parasetamoli, olivat 
yleisin lasten käyttämä itsehoitolääkeryhmä. Kalaöljy ja rasvahapot sekä probiootit olivat lasten yleisimmin 
käyttämät täydentävät ja vaihtoehtoiset valmisteet.  
Vanhemman sosioekonomisella asemalla, kuten koulutuksella ja tuloilla, ei ollut yhteyttä lasten terveyteen 
tai itselääkityksen käyttöön, kun taas vanhemman asenteella lääkkeiden käyttöä kohtaan oli yhteyttä etenkin 
täydentävien ja vaihtoehtoisten valmisteiden käyttöön. Lapset, joiden vanhemmat suhtautuivat positiivisesti 
reseptilääkkeiden käyttöön, käyttivät harvemmin täydentäviä ja vaihtoehtoisia valmisteita kuin ne lapset, 
joiden vanhemmat suhtautuivat niiden käyttöön negatiivisesti. Vanhemman positiivinen suhtautuminen 
itsehoitolääkkeiden käyttöön ja toisaalta myös pelot lääkkeiden käyttöä kohtaan olivat sen sijaan 
myötävaikuttavia tekijöitä lapsen täydentävien ja vaihtoehtoisten valmisteiden käytölle. 
Tämän tutkimuksen mukaan suomalaisten lasten terveydentila on hyvä, vaikka oireiden esiintyminen ja 
itselääkityksen käyttö on yleistä. Vanhemman sosioekonominen asema ei ollut yhteydessä lasten terveyteen 
tai itselääkityksen käyttöön. Vanhempien asenteilla, kuten peloilla lääkkeiden käyttöä kohtaan, oli sen sijaan 
merkitystä lasten itselääkityksen, erityisesti vaihtoehtoisten ja täydentävien valmisteiden käyttöön. 
Terveydenhuollon ammattilaisten tulisi varmistaa, että vanhempien lapsille antama itselääkitys toteutetaan 
kotona turvallisesti. Vanhempien näkemykset lääkkeiden käyttöä kohtaan tulee myös huomioida 
lääkeneuvonnassa. 
 
 
Luokitus: QV 55, QV 57, WB 120, WB 141.4, WB 327, WB 890 
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Definitions 
Complementary and alternative medicine (CAM) 
Complementary and alternative medicines (CAMs) are usually regarded as products and 
practices that are not part of conventional medicine, and which may be used as a 
complement or alternative to conventional care (National Center for Complementary and 
Alternative Medicine (NCCAM) 2014). In the literature review of this thesis, the term CAM 
includes a broad concept of products and practices depending on the cited publications. In 
the empirical part of this study, CAM is defined as traditional herbal medicinal products, 
homeopathics and anthroposophic products, and food supplements (excluding vitamin 
supplements) that are not regarded as medicines in Finland. Thus, practices such as massage 
therapy, chiropractic and acupuncture are excluded. 
 
Child 
The term child usually refers to humans from birth up to 18 years of age (European 
Medicines Agency (EMA) 2013, Child Welfare Act 417/2007). Adolescents are usually 
defined as population over 11 years of age (e.g. Rimpelä et al. 2004, von Rueden et al. 2006, 
Johnson and Wang 2008). In the literature review, the term child/children refers to children 
mainly under 19 years of age depending on the reference used. In the empirical part of this 
study, the term child is defined as children under 12 years of age, following the International 
Conference of Harmonization (ICH 2000) definition of children as 2- to 11-year-old and 
adolescents from 12 up to 18 years. 
  
Conventional care/medicine 
Conventional care and/or medicine encompasses medical treatments that are provided by 
registered health care professionals (NCCAM 2014). 
 
Food supplement 
Food supplements are products that usually resemble a medicinal product in their purpose 
of use and as they have the form of a tablet, pill, capsule, extract, powder, concentrate or 
liquid (Asetus ravintolisistä 78/2010, 2§). However, no medicinal purpose for the use may 
be presented. Food supplements are used as small doses to complement the diet, but the 
amount of energy they contain is low. They may contain, e.g., vitamins and minerals, or 
other ingredients, such as fatty acids or garlic, that may have physiological effects (Finnish 
Food Safety Authority (Evira) 2011, Evira 2013). 
 
Health 
The medical definition for health could be absence of disease whereas, for example, 
psychologists’ view on health concentrates on needs and need fulfilment (Schulz and 
Holdford 1996). World Health Organization (WHO) defines health as physical, mental and 
social well-being, which does not merely mean an absence of a disease (WHO 1948). In this 
study, health is operationalized as self-rated health, the prevalence of long-term diseases 
and the occurrence of psychosomatic symptoms among children reported by their parents. 
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Herbal medicinal product 
Herbal medicinal products have been classified as traditional herbal medicinal products or 
herbal medicinal products since 2005 (Finnish Medicines Agency (Fimea) 2013a). A herbal 
medicinal product contains herbal substances, herbal preparations or a combination of these 
as their active agents. Also other terms, such as natural remedies, may be used when 
speaking about herbal medicines (Hanssen et al. 2005). They are usually abbreviated as 
CAMs. In Finland, however, herbal medicinal products need marketing authorization by 
Fimea or European Medicines Agency (EMA), and are thus regarded as medicines (Fimea 
2013). 
 
Home remedy 
In this study, home remedy is used to refer to different ways to treat children’s self-limiting 
conditions at home, excluding medicine use. This could include remedies such as onions 
with brown sugar for coughing or ice water for sore throat (Gerrits et al. 1996). 
 
Homeopathic and anthroposophic products 
Homeopathic and anthroposophic products are medicinal products that are manufactured 
of homeopathic stocks using homeopathic manufacturing procedure, which is described in 
the European Pharmacopoea (Lääkelaki 395/1987, 5b§, Fimea 2013).  The official 
Pharmacopoea of a member state may also be used if the manufacturing process is not 
described in the European Pharmacopoea. 
 
Over-the-counter (OTC) medicine 
Over-the-counter medicine is a product that can be purchased from pharmacies without a 
prescription (Sosiaali- ja terveysministeriön asetus lääkkeen määräämisestä 726/2003), and 
it may have the form of a tablet, capsule, liquid or suppository, for example. OTC medicines 
are meant for alleviating, treating or preventing self-limiting conditions or for improving 
health (Sosiaali- ja terveysministeriön asetus lääkkeen määräämisestä 726/2003). 
 
Prescribed medicine 
Prescribed medicine is a product that may be dispensed from a pharmacy only with a 
prescription prescribed by a physician (Sosiaali- ja terveysministeriön asetus lääkkeen 
määräämisestä 726/2003). 
 
Psychosomatic symptom 
Psychosomatic symptoms are usually regarded as various physical and mental symptoms 
that are connected to each other and for which no specific reason to a single symptom may 
be found. Different studies have included for example back pain, headache, sleep disorders 
and dizziness as psychosomatic symptoms (e.g. Berntsson and Köhler 2001, Reinhardt 
Pedersen and Madsen 2002). In the empirical part of this study, psychosomatic symptoms 
are operationalized as symptoms of anxiety, sleep disorders, fatigue or dizziness, and 
depression. 
 
Self-care 
Self-care is a broad concept that encompasses all kinds of practices people do to maintain 
and improve health and to treat and prevent illnesses (WHO 1998, Ministry of Social Affairs 
and Health 2011). It comprises both individual and environmental factors such as hygiene, 
nutrition, sports, living conditions and socioeconomic factors. Self-medication is also a part 
of self-care. 
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Self-medication 
Self-medication is usually understood as a way of treating self-limiting conditions by using 
medicines (WHO 1998). It may also include herbal medicines, traditional products, and 
prescribed medicines not originally prescribed for the purpose at hand (WHO 1998, Lilja et 
al. 2008). In this study, self-medication is operationalized as the use of over-the-counter 
(OTC) medicines and complementary and alternative medicines (CAMs). 
 
Socioeconomic background 
Socioeconomic background has been defined in several ways depending on the source. Most 
of the studies concerning childhood health have included education level as one indicator 
of socioeconomic background in addition to income (e.g. Berntsson and Köhler 2001, Chen 
et al. 2006a, Chen et al. 2006b), whereas some studies have operationalized socioeconomic 
background only as occupational status of a parent (West and Sweeting 2004, Melchior et 
al. 2007). In the empirical part of this study, socioeconomic background is operationalized 
by the highest educational background of a responding parent, household net 
income/month, and working status.  
 
Traditional herbal medicinal product 
Traditional herbal medicinal product is a medicinal product that consists of herbal 
substances or herbal preparations or combinations of these as active ingredients, and is 
meant for human use (Lääkelaki 395/1987, 5a§, Fimea 2013). It may also include vitamins 
and minerals if they improve the effect of herbal substances. 
 
Vitamin 
In Finland, a vitamin product may be classified as a registered medicine by the Finnish 
Medicines Agency, or as a food supplement when announcement of a new product is 
required for the Finnish Food Safety Authority (Finnish Food Safety Authority 2011, Finnish 
Food Safety Authority 2013). The use of vitamins among Finnish children has been reported 
in study II.   
  
 
1 Introduction 
Self-care using self-medication is a common way to treat minor self-limited conditions (Lilja 
et al. 2008). It has been estimated that in 90% of cases, people treat their symptoms with self-
medication (Ahonen 2008). Over-the-counter (OTC) medicines are typically used to treat 
symptoms, but complementary and alternative medicines (CAMs) also have an important 
role in self-care (WHO 1998).  
The significance of self-medication has increased during the last decades due to, for 
example, an increasing trend of switching prescribed medicines to OTC medicine status in 
many countries (WHO 2000). In Finland, nearly 40 prescribed medicines have been switched 
to OTC medicine status since 1986 until 2007 (Pappila 2008). In European countries, the 
widest selection of OTC medicines can be found in the United Kingdom and Germany, and 
the smallest in Croatia and Greece (Niskanen 2012). The selection of OTC medicines in 
Finland may be considered as slightly smaller than in European countries on average. The 
general knowledge of self-medication has also increased among people, due to increased 
information sources of self-medication on the Internet and related communication systems 
(WHO 2000). 
It has been estimated that about half of the customers in pharmacies in Finland purchase 
some self-medication (Ovaskainen and Teräsalmi 2010). In spite of the wide use of self-
medication, OTC medicines, for example, accounted for only 12% (323 million euros) of the 
total sales in pharmacies in Finland 2012, while prescription medicines accounted for 71% 
(1943 million euros) (Finnish Medicines Agency and Social Insurance Institution 2013). 
There are no official sales figures for CAMs. According to a prognosis of sales in Pharmacies 
for the year 2013, 7% of sales consist of other products, not regarded as medicines, while the 
corresponding figure for OTC medicines was 14% (Suomen Apteekkariliitto 2013). 
However, most of the CAM products and practices are provided outside pharmacies. In 
2012, analgesics and medicines for the alimentary tract were the most common OTC 
medicines that had been sold from pharmacies according to their retail sale price or 
wholesaling price (Finnish Medicines Agency and Social Insurance Institution 2013). 
Ibuprofen was the most common analgesic sold, followed by paracetamol; laxatives were 
the most common medicines for the alimentary tract. 
Among adult population, the prevalence of the use of OTC medicines has been found to 
be 23−28 per cent, depending on the age groups and recall period used (Del Rio et al. 1997, 
Bradley et al. 1998, Sihvo et al. 2000, Martins et al. 2002). Antiobesity medicines, laxatives 
and analgesics/antipyretics have been the most common OTC medicines reported (Del Rio 
et al. 1997, Sihvo et al. 2000, Martins et al. 2002). In contrast, the prevalence of the use of 
CAMs has varied between 12 to 42 per cent depending on the definition of CAM and the 
recall period used (Eisenberg et al. 1998, Hanssen et al. 2005, Barnes et al. 2008). The most 
common CAM products used among adult population have been reported to be vitamins 
and minerals, and natural remedies (Hanssen et al. 2005, Eisenberg et al. 1998, Barnes et al. 
2008). Among CAM therapies, homeopathics, chiropractic, massage and acupuncture have 
been the most widely reported.  
Self-care among children differs from that among adults, since it is usually the parent 
who makes the decision on the treatment used for a child (Lilja et al. 2008). Self-care and the 
use of self-medication, especially OTC medicines, among children were a point of interest 
among researchers particularly in the 1990s (e.g. Irvine and Cunningham-Burley 1991, 
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Kogan et al. 1994, Holme 1995, Cantrill et al. 1996, Del Rio et al. 1997, Bruijnzeels et al. 1998). 
After that, research in this field has been less common (e.g. Allotey et al. 2004, Slone 
Epidemiology Center 2006, Uijen et al. 2008, Du and Knopf 2009a, Trajanovska et al. 2010a). 
Most of the studies have been carried out among selected population groups through 
schools (Cantrill et al. 1996) or health care centers, for example (e.g. Bruijnzeels et al. 1998, 
Uijen et al. 2008, Trajanovska et al. 2010a), but some are population-based (Kogan et al. 1994, 
Slone Epidemiology Center 2006, Du and Knopf 2009a). The use of CAMs among children 
has become a point of interest among researches especially in the 2000s (e.g. Simpson and 
Roman 2001, Menniti-Ippolito et al. 2002, Smith and Eckert 2006, Barnes et al. 2008, Zuzak 
et al. 2010, Nichol et al. 2011). Most of the studies have been conducted among hospital 
patients, for example (e.g. Madsen et al. 2003, Lim et al. 2005, Jean and Cyr 2007, Zuzak et 
al. 2010), and fewer are population-based (Menniti-Ippolito et al. 2002, Barnes et al. 2008, 
Du and Knopf 2009). Only a few studies have studied the use of OTC medicines and CAMs 
together as population-based (Slone Epidemiology Center 2006, Du and Knopf 2009a, Du 
and Knopf 2009b). 
In Finland, the latest studies about the use of self-medication among children have been 
carried out in the 1990’s (Bush et al. 1996, Arinen et al. 1998). The use of self-medication 
among children has been studied as part of population-based interview studies to 
households about health and the use of health services in Finland (Klaukka et al. 1990, 
Arinen et al. 1998). These studies have been conducted since 1964 by the Social Insurance 
Institution, with the last ones carried out in 1995 and 1996 as a collaborative effort by the 
Social Insurance Institution and the National Research and Development Centre for Welfare 
and Health. The studies focused on the whole Finnish population including children under 
15 year-old. The use of OTC medicines among children was measured in 1987 and 1995/96 
in these studies, and the use of complementary and alternative medicines in 1995/96. 
However, there is a lack of information about the most common OTC and CAM products 
used in 1995/96 (Arinen et al. 1998). Self-care and self-medication in Finland has also been 
explored as part of international co-operation involving researchers from Greece, Spain, 
USA, Italy, Netherlands, Germany, Yugoslavia, Denmark, England and Finland (Bush et al. 
1996). This study had both quantitative and qualitative components, including 19 to 215 
children in different countries. 
The aim of this study was to explore the health and the use of self-medication among 
Finnish children and factors associated with self-medication. Self-medication includes the 
use of OTC medicines and CAMs. In the literature review, self-care process and the use of 
self-medication among children are described, including factors associated with self-
medication. Studies published mainly in the 2000s are included, with the exception of the 
last population-based Finnish studies (Klaukka et al. 1990, Arinen et al. 1998) and a few 
international studies of self-care and self-medication that were considered valuable for this 
survey (Kogan et al. 1994, Bush et al. 1996, Eisenberg et al. 1998). As the context of this thesis, 
the Finnish health care system and children’s health in Finland are also described.  
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2 Context 
2.1 HEALTH CARE IN FINLAND 
In Finland, primary public health care services are offered to all citizens in municipalities 
for a small fee (Ministry of Social Affairs and Health 2013, Health Care Act 1326/2010, 4§ 
and 24§, Asiakasmaksulaki 734/1992, 1§ and 2§, Asiakasmaksuasetus 912/1992, 7§). Special 
health care is offered in twenty hospital districts with one central hospital in each. Five of 
these hospitals are University hospitals, in Helsinki, Turku, Tampere, Kuopio and Oulu. In 
addition, private health care supports public health care by offering services directly to 
citizens or municipalities (Ministry of Social Affairs and Health 2013). Part of the fees in 
private health care is reimbursed by Social Insurance. 
Mothers’ and children’s health is monitored regularly in prenatal care and child welfare 
clinics when the child is under school age (Health Care Act 1326/2010, 15§, Valtioneuvoston 
asetus neuvolatoiminnasta, koulu- ja opiskeluterveydenhuollosta sekä lasten ja nuorten 
ehkäisevästä suun terveydenhuollosta 380/2009, 9§). The aim is to ensure the physical, 
psychological and social development of a child and to promote the welfare of the family. 
Up to the time when the child is one year old, there are at least nine actoral visits, at least 
two of them performed by a physician, at the ages of 4−6 weeks and 8 months.  The health 
of children over one year of age is monitored at least yearly, and once the child is of school 
age, his/her health is monitored yearly by school health services (Health Care Act 1326/2010, 
16§, Valtioneuvoston asetus neuvolatoiminnasta, koulu- ja opiskeluterveydenhuollosta 
sekä lasten ja nuorten ehkäisevästä suun terveydenhuollosta 380/2009, 9§). Prenatal care, 
child welfare clinic and school health care are all free of charge (Asiakasmaksulaki 734/1992, 
Ministry of Social Affairs and Health 2013). 
2.2 THE REGULATORY FRAMEWORK AND SELLING PATHWAYS OF SELF-
MEDICATION IN FINLAND  
2.2.1 Over-the-counter medicines 
Over-the-counter (OTC) medicines are medicinal products that need a marketing 
authorization by the European Medicines Agency (EMA) or Finnish Medicines Agency 
(Fimea) in Finland (Lääkelaki 395/1987, 20a§ and 21§, Table 1). Their quality, safety and 
effectiveness needs to be proven by pre-clinical and clinical studies and their benefit-harm 
interrelationship has to be positive when taking into account the purpose of use (Lääkelaki 
395/1987, 21§, European Commission 2006). 
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Table 1. The legal requirements and selling pathways of self-medication (European Medicines 
Agency (EMA), Finnish Food Safety Authority (Evira), Finnish Medicines Agency (Fimea). 
 
Product Self-medication 
Over-the-counter 
(OTC) medicine 
Complementary and alternative medicine (CAM) 
Traditional 
herbal 
medicinal 
product 
Homeopathic and 
anthroposophic 
product 
Food supplement 
Legal 
requirements 
Marketing 
authorization by 
FIMEA or EMA 
Registration by 
FIMEA or EMA 
Marketing 
authorization or 
registration by 
FIMEA or EMA 
Reporting to Evira 
Retail outlet Community 
pharmacies 
without a 
prescription 
Community pharmacies, some 
preparations also from grocery stores 
and health food shops 
Community 
pharmacies, 
grocery stores and 
health food shops 
 
There were 550 marketing authorizations in Finland in November 2013 that have the 
status of OTC medicine for humans (Voipio Tinna, Fimea, personal information 2013). OTC 
medicines can be sold only in pharmacies (Lääkelaki 395/1987, 38§). At the end of the year 
2012, there were 818 pharmacies in Finland, 18 of which were owned by the Universities of 
Helsinki (17 pharmacies) and Eastern Finland (one pharmacy) (Suomen Apteekkariliitto 
2012). This means that there is approximately one pharmacy per 6,600 inhabitants. This 
figure is higher than in other Nordic Countries. For example in Sweden there are 
approximately 7,800 inhabitans per one pharmacy and 6,960 in Norway. OTC medicines are 
not reimbursed by Social Insurance. However, some of the OTC medicines (e.g. eye drops 
for allergy symptoms, some corticosteroid ointments for atopic eczema) are reimbursed by 
the Social Insurance in Finland if purchased with a prescription (The Social Insurance 
Institution of Finland 2013a). 
2.2.2 Complementary and alternative medicines 
There is no consistent regulation concerning complementary and alternative medicine 
(CAM) products in Finland. If there is no basis for a marketing authorization, traditional 
herbal medicinal products need to be registered by Fimea or EMA before getting into 
market, whereas homeopathic and anthroposophic products need a marketing 
authorization or a registration (Lääkelaki 395/1987, 22§ and 22a§, Fimea 2013, Table 1). In 
contrast, the Finnish Food Safety Authority (Evira) monitors the marketing of food 
supplements (Maa- ja metsätalousministeriön asetus ravintolisistä 78/2010, Table 1). CAMs 
are not reimbursed by Social Insurance in Finland.  
 
Traditional herbal medicinal products 
The requirements for the registration of traditional herbal medicinal product are that it has 
been in medicinal use continuously at least 30 years, of which at least 15 years in the 
European Union (Lääkelaki 395/1987, 22§, Fimea 2013, Table 1). In May 2013, there were 
eight registered traditional herbal medicinal products (e.g. Atrogel®, Crataegus®, 
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Gingkomax® and Kingovital®) in Finland, and all of them may be sold not only in 
community pharmacies but also in grocery stores and health food shops (Lääkelaki 
395/1987, 38a§, Fimea 2013).  
 
Homeopathic and anthroposophic products 
For the marketing authorization of homeopathic and anthroposophic products, the quality 
of the product must be proven as for medicines in general (Fimea 2013, Table 1). The safety 
of the product needs to be shown by presenting original studies or with published literature 
that show that the dilution is safe in relation to the administration route. The effect of the 
product does not have to be demonstrated, but the homeopathic use needs to be shown on 
the basis of literature. However, if the purpose of use for the product is presented, the effect 
of the product needs to be proven as for other medicinal products. 
The requirements for the registration of homeopathic and anthroposophic products are 
that they are meant to be administered orally or externally, and no purpose of use is 
presented (Lääkelaki 395/1987, 22a§, Fimea 2013). Sufficient degree of dilution is also 
required to ensure safety: the medicinal product may not contain more than one part per 
10,000 of the mother tincture, or at maximum 1/100th of the smallest dose used as allopathy 
that usually requires physician’s prescription. 
There are over 505 registered homeopathic products and 90 registered anthroposophic 
products on the Finnish market (Fimea 2013). Homeopathic products may be sold in grocery 
stores, for example, whereas most of the registered anthroposophic products may only be 
sold in pharmacies (Lääkelaki 395/1987, 38a§, Fimea 2013, Table 1).There are no 
homeopathic or anthroposophic products that have marketing authorization in Finland. 
 
Food supplements 
Before a new food supplement gets into the market, the Finnish Food Safety Authority 
(Evira) needs to be apprised (Maa- ja metsätalousministeriön asetus ravintolisistä 78/2010, 
Table 1). The Finnish Food Safety Authority also needs to be informed if there are some 
changes to the content of the product or if it leaves the market. The food supplement needs 
to be suitable for human use in terms of its chemical, microbiological and physical quality, 
and the information included may not be misleading for the consumer (Elintarvikelaki 
23/2006). 
There are approximately 3500−4000 food supplements on the market in Finland, which 
are usually sold in community pharmacies, grocery stores and health food shops (Finnish 
Food Safety Authority 2011, Table 1). Food supplements are not reimbursed by the Social 
Insurance in Finland. 
2.3 BENEFIT AND RISKS OF SELF-MEDICATION 
Self-care and self-medication (including over-the-counter (OTC) medicines and 
complementary and alternative medicines (CAMs)) have many benefits for individuals and 
for society as well. For individuals, they are a rapid and easy way to treat self-limiting 
conditions with lower total costs compared to prescribed medicines (WHO 2000). It also 
highlights individuals’ own responsibility for their health. For society, the use of self-
medication is beneficial since it decreases health care costs (WHO 2000, Pappila 2008), which 
tend to be rising in many countries (National Institute for Health and Welfare 2013, 
Organization of Economic Cooperation and Development (OECD) 2011). Self-medication 
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also decreases costs for employers because it enables employees to continue their work 
instead of contacting health care services and taking sick leave (WHO 2000).  
However, self-medication may also have health risks if the dosage instructions are not 
followed, and if it is used for the wrong indication, in which case it may cover the symptoms 
of a more serious disease (WHO 2000, Reinstein 2005, European Commission 2006). It may 
also involve risk of interactions when used together with prescribed medicines (WHO 2000, 
Reinstein 2005, Ahonen 2008). Since self-medication is an easy way to prevent and take care 
of health, it may sometimes be associated with low motivation to life-style changes; for 
example, if antacids are used instead of reducing coffee intake.  
Among children, the use of self-medication may be beneficial to parents in a situation 
where they need to continue their own work and the child is having a symptom that does 
not require the child to stay at home (Allotey et al. 2004). However, self-medication might 
also predispose to inappropriate use if it is given to a child in a case when the parent needs 
to go work and the child should have been cared for at home. 
2.4 HEALTH OF FINNISH CHILDREN 
In 1996, nearly 22% of Finnish children under 15 years of age had some long-term disease 
(Arinen et al. 1998, Takala et al. 2001). Based on a population-based survey, the prevalence 
had increased since the year 1987, when approximately 12% of children of this age were 
reported to have some long-term disease. Having a long-term disease has been more 
common among older children, aged 7−14 years, than among younger ones, but the 
prevalence increased significantly among both age groups between the two studies (from 
15% to 23% among 7-to 14-year-old children, and from 9% to 20% among 0- to 6-year-old 
children). However, among Finnish adolescents (aged 12 to 18 years) the prevalence of long-
term disease was quite stable between the years 1980 and 2007, approximately 10% (range 
7 to 12% during these years) (Rimpelä et al. 2004, Luopa et al. 2008). 
The most common long-term diseases among Finnish children have been asthma and 
allergies (Arinen et al. 1998, Takala et al. 2001).  Asthma medications have also been the 
most common medicines reimbursed for children, followed by medicines for diabetes, 
epilepsy and rheumatoid arthritis (Arinen et al. 1998, Takala et al. 2001, The Social Insurance 
Institution of Finland 2013b). The prevalence of asthma and allergies has increased among 
children during the past decades, which also mostly explains the increase in the prevalence 
of long-term diseases between the study years 1987 and 1996 among children aged under 
15 years (Takala et al. 2001).  
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3 Self-Care Process Among Children
Self-care consists of several actions laymen need to consider based on the present illness, 
how they evaluate the severity of the symptom and how they consider the needed action. 
When a child gets ill, this procedure is exceptional, because the decision-maker on behalf of 
a child is usually the parent not the child him- or herself (Lilja et al. 2008). Thus, the decision-
process of how different illnesses should be treated is largely based on the views of a parent. 
Figure 1 provides one model of how the self-care process among children can be described. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Self-care process among children (modified from Lilja 2008). 
3.1 DETECTION OF SYMPTOMS 
The first stage in the self-care process is that a persistent illness is detected (Figure 1). 
Usually it is a family member who may notice a symptom first rather than the individual 
him/herself (Lilja et al. 2008).  
In the case of children, it is usually the mother who notices first that the child is not feeling 
well (Aramburuzabala et al. 1996, Vaskilampi et al. 1996, Figure 1). Sometimes also the child 
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him/herself may first notice being ill, which is afterwards confirmed by the mother 
(Aramburuzabala et al. 1996, Gerrits et al. 1996). Parents typically compare the child’s 
behaviour to what is normal for their child (Lagerløv et al. 2003). Consequences of an illness 
may be that the child does not eat or drink as usual, or the parent sees some changes in the 
child’s behaviour (Gerrits et al. 1996, Vaskilampi et al. 1996).  
The most common symptoms children experience are usually respiratory symptoms; 
symptoms of cold, high temperature, cough, headache or other pains, and stomach ailments 
(Spencer and Coe 2000, Hay et al. 2005, Wong et al. 2007, von Linstow et al. 2008, Ishida et 
al. 2012). Usually, especially high fever is seen as an obvious sign of an illness (Lagerløv et 
al. 2003). The symptoms of cold and respiratory symptoms are common particularly among 
children under school age, whereas the prevalence of headaches and other pains usually 
increase with age and are more prevalent among adolescents (Halldórsson et al. 2000, 
Haugland et al. 2001, Reinhardt Pedersen and Madsen 2002, Petersen et al. 2003, Uijen et al. 
2008, Ishida et al. 2012). Children experience also different psychosomatic symptoms, such 
as tension, nervousness, dizziness and sleep disorders, which are more prevalent among 
adolescents than younger children (Halldórsson et al. 2000, Reinhardt Pedersen and Madsen 
2002). Despite the fact that children experience various symptoms during their life, their 
overall health status has usually been reported  as being excellent, good or fairly good by 
their parents or by the children themselves (e.g. Office for National Statistics 2002, Rimpelä 
et al. 2004, Emerson et al. 2006, Johnson and Wang 2008, National Institute for Health and 
Welfare 2012). 
3.2 SYMPTOM-JUDGEMENT STAGE 
After a symptom is detected, its seriousness needs to be evaluated (Figure 1). It is usually 
the mother who evaluates the severity of the child´s symptom (Vaskilampi et al. 1996, Figure 
1). Depending on the severity of the symptom, parents may consult their family and friends 
or a pharmacy to ask for help or share the responsibility when evaluating their child’s 
symptom (Birchley and Conroy 2002, Lilja et al. 2008). If they regard the symptom as minor, 
they usually only want to have reassurance for their own thoughts.  
Parents evaluate the severity of the symptom on the ground of the child’s behaviour, face 
colour and occurrence of uncommon symptoms (Gerrits et al. 1996, Figure 1). The 
temperature level plays a major role when determining the severity of an illness and the 
action applied. Many parents regard high temperature as one of the signs of severe 
symptoms and base their decision as to how to treat an illness on the temperature level 
(Gerrits et al. 1996, Vaskilampi et al. 1996). However, there are differences in the 
temperature level parents regard as fever, and also in how they define high temperature 
(Walsh et al. 2007). The level considered as fever by parents has varied between 36.7°C and 
40.5°C in different studies (Vaskilampi et al. 1996, Walsh et al. 2007, Walsh et al. 2008, Erkek 
et al. 2010).  
3.3 THE STAGE OF SELECTING COURSES OF ACTION  
After a child’s symptom is evaluated, the parents need to decide how to deal with the 
symptom, and whether the child should stay at home or whether he/she may go to school 
(Aramburuzabala et al. 1996, Gerrits et al. 1996, Vaskilampi et al. 1996). The decision is 
mainly based on the severity of the illness.  
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It has been shown that it is the mother who takes care of the child and decides how to 
treat the symptom when the child is ill (e.g. Aramburuzabala et al. 1996, Gerrits et al. 1996, 
Vaskilampi et al. 1996, Geissler et al. 2000, Lagerløv et al. 2003, Figure 1). However, in a 
study of different locations in Spain, Greece, Finland, and the United States, the parents in 
Finland and Spain also mentioned the father as a decision-maker more often than parents 
in other locations, whereas in Spain and Greece also grandparents had a role in taking care 
of their grandchild during an illness episode (Aramburuzabala et al. 1996, Vaskilampi et al. 
1996). 
 
3.3.1 Home remedies 
If the parent considers the child to have non-severe, mild illness, it is usually taken care at 
home (Gerrits et al. 1996, Figure 1). Parents may wait and see how the symptom develops 
and use home remedies to help the child to feel better. Various drinks, such as tea and fruit 
juices, and massage e.g. in the case of back and belly pain may be given to the child. 
 
3.3.2 Self-medication 
Self-medication is usually given as a first course of action if the parent considers that the 
child has more severe, moderate symptoms, or if the symptoms have lasted for a few days 
without any progress (Gerrits et al. 1996, Wong et al. 2007, Figure 1). Parents may consider 
the need for self-medication also on the ground of additional factors, such as the child’s 
behaviour and well-being, and whether there are, e.g., sleep disturbances or loss of appetite 
(Walsh et al. 2007). Usually the action applied is based on their own experience and 
information they have (Gerrits et al. 1996). Family and friends may also have a role, mainly 
to share experiences with rather than asking for advice. Mass media may also be a source of 
information for parents. 
 
3.3.2.1 Over-the-counter (OTC) medicines 
OTC medicines purchased from a pharmacy or independently taken prescription medicines 
from a medicine cabinet at home, even if not originally prescribed for the present illness, are 
typically used as a form of self-medication (Gerrits et al. 1996, Lilja et al. 2008, Figure 1). 
They may also be used together with home remedies (Ahonen et al. 1996). According to 
different studies, 8−63% of children had used some OTC medicine depending on the recall 
period, age of the children, and how the use of OTC medicines is defined in different studies 
(e.g. Kogan et al. 1994, Westerlund et al. 2008, Carrasco-Garrido et al. 2009, Du and Knopf 
2009a, Moraes et al. 2011). In Finland, the last studies from 1987 and 1995−96 showed that 
approximately 13% of children under 7 years of age and 8% of children 7−14 years of age 
had used some OTC medicine in the preceding two days in 1995−96 (Arinen et al. 1998). The 
proportions were mainly on the same level as in the year 1987, with a slight decrease among 
0- to 6-year-old children (15% of 0- to 6-year-old children and 8% of 7- to 14-year-old 
children in 1987) (Klaukka et al. 1990). 
The use of OTC medicines has been common especially among children under school age 
(under 7 years) (Klaukka et al. 1990, Arinen et al. 1998). However, some studies have found 
the use of self-medication to be most common among adolescents (14- to 17-year-old) (Du 
and Knopf 2009a, Ishida et al. 2012). According to genders, the findings of the use of OTC 
medicines are somewhat inconsistent. A few studies have indicated that the use of OTC 
medicines is more common among girls than among boys (Ahonen et al. 1996, Tobi et al. 
2003, Du and Knopf 2009a), especially at the age of 7 years and over (Arinen et al. 1998, 
Holstein et al. 2003, Tobi et al. 2003), whereas one study found this association to be reversed 
if used occasionally (Westerlund et al. 2008).  
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The most common OTC medicines given to children have been analgesics and 
antipyretics, especially paracetamol, and other cough and cold medicines (e.g. Klaukka et 
al. 1990, Kogan et al. 1994, Arinen et al. 1998, Vernacchio et al. 2009), which are medicines 
that may be used to treat typical childhood symptoms, such as fever and pain (Lagerløv et 
al. 2003, Trajanovska et al. 2010b). These medicines have also been the most common 
preparations that parents usually purchase from the pharmacy and already have  at home, 
in addition to vitamin and mineral supplements (Ahonen et al. 1996, Wong et al. 2007, 
Trajanovska et al. 2010a, Trajanovska et al. 2010b). However, parents have sometimes 
reported using OTC medicines such as paracetamol or sedative antihistamines as “social 
medication” to induce sleep or to calm the child down (Allotey et al. 2004, Trajanovska et 
al. 2010b). 
 
3.3.2.2 Complementary and alternative medicines (CAMs) 
CAMs, including different products and therapies, may also be used as a form of self-
medication, although they are not usually the first course of action (Gerrits et al. 1996). Based 
on previous studies, the use of CAMs among children varies between 4% and 67%, 
depending on how CAM has been defined and/or the length of the recall period (e.g. 
Menniti-Ippolito et al. 2002, Slone Epidemiology Center 2006, Smith and Eckert 2006, Barnes 
et al.  2008, Wadhera et al. 2011, Gottschling et al. 2013). The use has been common especially 
in families were either parent uses some CAM (e.g. Menniti-Ippolito et al. 2002, Barnes et al. 
2008). In Finland, the prevalences of the use of CAMs among children was found to be 
approximately 4% among children aged under 7 years and 6% among 7- to 14-year-old 
children in 1996 (Arinen et al. 1998). 
CAM use has been consistently found to be equally common among both genders 
(Simpson and Roman 2001, Madsen et al. 2003, Crawford et al. 2006, Barnes et al. 2008, Du 
and Knopf 2009b), whereas according to age, there are distinctions in the results between 
different studies. Some studies have reported CAM use to increase with age, being most 
common among adolescents (Arinen et al. 1998, Loman et al. 2003, Lim et al. 2005, Barnes et 
al. 2008), while some studies have not found any association between child’s age and CAM 
use (Simpson and Roman 2001, Madsen et al. 2003, Noonan et al. 2004, Crawford et al. 2006, 
Smith and Eckert 2006). Some studies have found an association between age and gender 
and CAM use depending on the type of CAM used. For example, in the USA according to 
National Health Statistics reports 2008, girls were more likely to use mind-body therapies 
than boys (Barnes et al. 2008), and in an Australian study, massage was most commonly 
used among children aged 0−4 years (Smith and Eckert 2006). 
The most commonly reported CAMs given and used among children have been herbal 
medicines, chiropractic treatment, homeopathy, massage, and vitamins and minerals (e.g. 
Simpson and Roman 2001, Menniti-Ippolito et al. 2002, Madsen et al. 2003, Smith and Eckert 
2006, Jean and Cyr 2007, Barnes et al. 2008). In Finland, the most commonly used CAM 
products among children were not reported in the last study 1996, but the most frequently 
used CAMs in the whole study population, including children and adults, were calcium, 
silicon and vitamin C preparations (Arinen et al. 1998). 
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Indications for the use of CAM  
The reasons for using CAM for children have most commonly been to prevent, maintain 
and improve health, and to strengthen the immune system (e.g. Lim et al. 2005, Cincotta et 
al. 2006, Smith and Eckert 2006, Zuzak et al. 2009, Gottschling et al. 2013); especially herbal 
medicines and vitamins have been used for these purposes (Madsen et al. 2003, Smith and 
Eckert 2006). However, also a number of health conditions have been found to be associated 
with CAM use (Madsen et al. 2003, Barnes et al. 2008), and it has been reported that CAMs 
are also given to children for the treatment of typical childhood symptoms, such as 
respiratory symptoms, fever, cough and cold, colic or diarrhoea (e.g. Pitetti 2001, Smith and 
Eckert 2006, Walsh et al. 2007, Barnes et al. 2008, Araz and Bulbul 2011, Italia et al. 2012). 
Various treatments are used for these symptoms, such as herbal medicines and 
homeopathics (Lim et al. 2005, Italia et al. 2012). Sometimes CAMs are used for the treatment 
of musculoskeletal problems, such as back or neck pain (Loman 2003, Smith and Eckert 2006, 
Jean and Cyr 2007, Barnes et al. 2008); massage and chiropractic therapy are most commonly 
used for this purpose (Loman 2003, Smith and Eckert 2006). 
Many studies have also reported CAM use among children that have some chronic 
disease (Simpson and Roman 2001, Noonan et al. 2004, Low et al. 2008, Oshikoya et al. 2008, 
Wood and Finlay 2011), such as cancer (e.g. Laengler et al. 2008, Tomlinson et al. 2010), 
asthma (e.g. Sidora-Arcoleo et al. 2007, Oshikoya et al. 2008, Shen and Oraka 2012), autism 
(Wong and Smith 2006), or diabetes (Loman 2003, Miller et al. 2008). In chronic diseases, 
CAMs are usually mainly meant for strengthening the immune system and helping to cope 
with the side effects of conventional care or symptoms of a disease rather than for treating 
a specific disease (e.g. Madsen et al. 2003, Wong and Smith 2006, Laengler et al. 2008, Wood 
and Finlay 2011). Usually they are used alongside conventional care (Shaw et al. 2006, 
Laengler et al. 2008, Wood and Finlay 2011). Among cancer patients one of the predictive 
factors where parents have given or considered giving CAM for their child have included  
poor prognosis, relapse of a disease or a child in palliative care, which implies that CAM is 
also used as a last resort (Gomez-Martinez 2007, Tomlinson et al. 2010). Among asthmatic 
children, poorly controlled asthma and the prescribed medication not having been effective 
have also been associated with the use of CAM (Shen and Oraka 2012).  
 
Referral for CAM use 
Most of the CAM treatments administered to children are self-initiated by the parents, or 
recommended by relatives and/or friends (e.g. Simpson and Roman 2001, Lim et al. 2005, 
Cincotta et al. 2006, Crawford et al. 2006, Zuzak et al. 2009, Wood and Finlay 2011, 
Gottschling et al. 2013). Parents have usually reported giving CAM to their child after 
having tried conventional medicines without success (Simpson and Roman 2001, Nichol et 
al. 2011, Wood and Finlay 2011). Sometimes CAM is used together with conventional 
medicines (Jean and Cyr 2007, Wood and Finlay 2011). However, one study reported that 
sometimes parents give OTC medicines to their child after trying CAMs without a success 
(Walsh et al. 2007). The reasons for choosing CAM have been the idea that they are safe, and 
on the other hand, fear of side effects and dissatisfaction with conventional medicines 
(Simpson and Roman 2001, Menniti-Ippolito et al. 2002), but also the opportunity to have 
more options in health care of children and to increase the likelihood that something is 
helpful for their child (Zuzak et al. 2009, O’Keefe and Coat 2010, Nichol et al. 2011).  
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3.3.3 Consulting a physician 
A physician is usually consulted in severe symptoms of a child, if the symptoms have lasted 
for a few days without any signs of getting better in spite of the self-medication or home 
remedies used (Ahonen et al. 1996, Gerrits et al. 1996, Ecklund and Ross 2001, Uijen et al. 
2008, Trajanovska et al. 2010a). A physician is also consulted if the symptoms appear rapidly 
and/or are such that the parent does not know how to treat them (Ecklund and Ross 2001, 
Lagerløv et al. 2003). Usually the decision-maker as to whether a physician should be 
contacted is the mother, but also fathers have a role in these decisions, especially in acute 
cases and at weekends (Gerrits et al. 1996). 
The most common reasons for consulting a physician have been respiratory symptoms, 
mainly ear infections, fever and rashes (Ecklund and Ross 2001, Takala et al. 2002, Hay et al. 
2005, Uijen et al. 2008). The type of symptom may have an effect on how soon a physician is 
consulted. For example, if the child has a high temperature, wheeziness, vomiting or 
diarrhoea, rash or earache, parents would seek advice within two days (Trajanovska et al. 
2010a). In contrast, in the case of sleep difficulties, for example, they would wait one week. 
A physician is usually consulted more often when the child is under school-age (Office 
for National Statistics 2002, Halldórsson et al. 2002, Uijen et al. 2008, Ishida et al. 2012), 
which is natural considering that younger children experience most often different 
symptoms, such as respiratory symptoms, especially infections, compared to older ones 
(Victorino and Gauthier 2009). Younger maternal age has been found to predict the use of 
health care service in children’s conditions (Ecklund and Ross 2001, Birchley and Conroy 
2002, Hay et al. 2005), which may be due to less experience in treating different symptoms 
compared to older parents. Also parents with one child have been found to consult a 
physician more commonly than parents with more than one child (Ishida et al. 2012). 
Families with one child have also been found to have more often prescribed medicines at 
home than families with more than one child (Ahonen et al. 1996).  
Living area may also have an effect on how common it is to consult a physician in 
children’s ailments. Some studies have shown that children living in urban areas use more 
health services than children living in rural areas (Halldórsson et al. 2002, Takala et al. 2002, 
Uijen et al. 2008). However, one study showed this association as reverse, and it was found 
that rural parents consulted a physician more often as a first course of action in a mild illness 
while urban parents tried first self-treatment (Hoa 2007). The decision-process may also 
depend on the costs and accessibility of health care services (Lilja et al. 2008, Aoyama et al. 
2012). In addition, if the child has private insurance, parents may contact medical care more 
readily than if they do not have insurance for their child (Duderstadt et al. 2006).  
3.4 FACTORS ASSOCIATED WITH HEALTH, SELF-CARE AND SELF-
MEDICATION AMONG CHILDREN  
3.4.1 Culture 
Culture plays an important role in how different symptoms are detected and regarded as a 
medical problem (Lilja et al. 2008, Figure 2). There are distinctions between countries in how 
parents perceive children’s symptoms and which actions they choose to take. There might 
also be cultural variations in the use of self-medication within a country. These differences 
have been found for example among children with the use of anti-asthmatic medication 
(Cantarero-Arévalo et al. 2013, Cantarero-Arévalo et al. 2014). 
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Figure 2. Factors associated with self-care and self-medication among children. 
 
Variations have been observed in the use of OTC medicines as symptom treatment 
concerning specific childhood symptoms (Vaskilampi et al. 1996). In Finland, parents 
usually try home remedies first, such as hot or cold drinks (Ahonen et al. 1996). This was 
also found in a descriptive study of different locations in Europe and the USA (Vaskilampi 
et al. 1996). In the USA, Spain and Greece, a majority of responding parents reported treating 
the child with OTC medicine when the child had fever compared to children in Finland, 
where only about half of the children were given OTC medicine to treat fever. In addition, 
the majority of responding parents (70%) in Greece and Spain consulted their physician 
when their child had fever whereas half of the parents in the USA and only one third of the 
parents in Finland consulted a physician (Vaskilampi et al. 1996). Consulting a physician 
rather than using OTC medicines for a child’s fever has also been found in Denmark and 
Japan. According to qualitative and quantitative studies, over 90% of parents reported 
taking their child to see a physician if he/she had high (39°C) fever (Jensen et al. 2010, 
Aoyama et al. 2012). The reasons for this were that parents felt they should not make their 
own judgements, and also because the medical treatment of children is free of charge 
(Aoyama et al. 2012). In contrast, no cultural differences have been seen as to which OTC 
medicine is most commonly used among children. Analgesics and antipyretics, especially 
paracetamol, have been the most widely reported OTC medicines in different studies from 
Europe and the USA (e.g. Klaukka et al. 1990, Kogan et al. 1994, Arinen et al. 1998, Slone 
Epidemiology Center 2006). 
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There are also cultural differences in the use of CAMs among children, determining 
which products and practices are most commonly used in different countries. Herbal 
medicine use in children has been commonly reported in Australia, United States and in 
Northern and Western Europe, such as Ireland, Wales and Denmark (e.g. Madsen et al. 2003, 
Lim et al. 2005, Crawford et al. 2006, Smith and Eckert 2006, Low et al. 2008, Barnes et al. 
2008, Huillet et al. 2011, Wadhera et al. 2011), whereas homeopathic remedies, for example, 
have been quite widely used in Canada, England, and Southern and Central Europe, such 
in Italy, Germany and Switzerland (Pitetti 2001, Simpson and Roman 2001, Menniti-Ippolito 
et al. 2002, Jean and Cyr 2007, Zuzak et al. 2010, Italia et al. 2012, Gottschling et al. 2013).  
There are also distinctions in the symptom treatment and CAM use between developing 
and developed countries. In developing countries, self-treatment has a major role in health 
care due to higher costs of private health care (Geissler et al. 2000). Herbal medicines are 
widely used for example for abdominal pain, wounds and skin infections. However, quite 
many (58%) of the mild symptoms in particular are also left untreated. The use of traditional 
medicines as symptom treatment in developing countries may also depend on the 
socioeconomic background of the parent. According to a qualitative study from South 
Africa, more highly educated parents preferred using OTC medicines for their child as 
symptom treatment whereas parents with low education preferred traditional medicines 
(Friend-du Preez et al. 2013). 
3.4.2 Parental socioeconomic background 
Parental socioeconomic background, mainly education, income and/or employment status, 
has been shown to have an impact not only on the use of self-medication among children, 
but also on the health of children (Figure 2).  
Several studies have shown that low parental socioeconomic background is associated 
with different adverse health variables of children (Emerson et al. 2006, von Rueden et al. 
2006, Victorino and Gauthier 2009), such as psychosomatic symptoms, chronic illnesses, 
and/or poorer self-rated health reported by their parent or themselves compared to children 
with high parental socioeconomic background (e.g. Halldórsson et al. 2000, West and 
Sweeting 2004, Bauman et al. 2006, Currie and Lin 2007, Johnson and Wang 2008, Victorino 
and Gauthier 2009). In addition, a few studies have also indicated that the presence of 
multiple social risk factors (e.g. poor education, poverty, family structure, and family 
conflict) have a cumulative effect on children’s poor health (Bauman et al. 2006, Larson et 
al. 2008) and that parental low socioeconomic background in childhood may also predict  
poor health in adulthood (Melchior et al. 2007). However, one study suggests that family 
income is not a major determinant of predicting child’s health (Currie et al. 2007). 
There are only few studies that have explored the association between parental 
socioeconomic background and children’s use of OTC medicines. Most studies have found 
that high socioeconomic background of at least one parent is positively associated with OTC 
medicine use among children and adolescents (Kogan et al. 1994, Ecklund and Ross 2001, 
Tobi et al. 2003, Ishida et al. 2012). It might be that more highly educated parents are more 
confident in using OTC medicines for their child (Aoyama et al. 2012). However, a reverse 
finding was made in a Danish study were low social class of adolescents, according to 
parents occupation, was found to be associated with increased use of medicines for specific 
symptoms compared to adolescents from higher social class (Holstein et al. 2004).  
CAM use among children has typically been found to be more common in high-income 
families, and/or with a more highly educated parent (e.g. Crawford et al. 2006, Smith and 
Eckert 2006, Du and Knopf 2009b, Zuzak et al. 2009, Birdee et al. 2010, Gottschling et al. 
2013). However, some studies have not found any significant association between parental 
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income and/or education and CAM use among children (e.g. Pitetti 2001, Simpson and 
Roman 2001, Zuzak et al. 2009, Huillet et al. 2011, Italia et al. 2012). Sometimes CAMs form 
an important part of symptom treatment in self-care due to their lower costs compared to 
conventional medicines, especially in low socioeconomic families (Barnes et al. 2008). 
3.4.3 Parental attitudes 
Attitudes have an impact on how different forms of self-medication are seen by the parents, 
and it has been shown that parental attitudes also affect how children’s self-limiting 
conditions are treated (Figure 2).  
 
Attitude toward OTC medicines 
Parents have various views concerning OTC medicines and medicine use for their children. 
According to a descriptive study, some parents consider that OTC medicines are not as 
effective as prescribed medicines, except for the ones that have been transferred from 
prescription only status (Ahonen et al. 1996). In addition, some OTC medicines, such as 
paracetamol, are regarded as safe by parents (Birchley and Conroy 2002, Lagerløv et al. 
2003), especially since they are sold over-the-counter (Birchley and Conroy 2002). In 
contrast, sometimes parents think that OTC medicines are unnatural for the human body 
(Ecklund and Ross 2001) and should only be used when needed (Ahonen et al. 1996, Gerrits 
et al. 1996). Parents have been shown to be worried about the adverse effects of medications 
used for fever and pain and regard them as harmful for the child (Walsh et al. 2007, Rony et 
al. 2010). According to descriptive studies, many parents also think that OTC medicines 
should be administered only at the lowest dose that helps (Gerrits et al. 1996, Rony et al. 
2010).  
However, the treated symptom may also cause worry for the parents if left untreated. For 
example, according to studies concerning the management of fever, most parents think that 
fever could be harmful for their child, causing e.g. seizure or brain damage (Walsh et al. 
2008, Erkek et al. 2010, Jensen et al. 2010). To avoid these harmful effects, lowering 
temperature level with OTC medicines is preferred, sometimes also at quite low levels of 
temperature. 
Previous studies have also shown that parental views, experiences, and attitudes toward 
medicines influence how they assess the need for medication for their children in different 
health conditions (Ecklund and Ross 2001, Kankkunen et al. 2008, Jensen et al. 2010). For 
example, it has been shown that parents with positive attitudes toward medicines are more 
willing to medicate their child’s pain than those who have negative thoughts on the matter 
(Rony et al. 2010).  
 
Attitude toward CAMs 
A typical feature of CAMs is that they are often regarded as natural and safe compared to 
Western drugs (Crawford et al. 2006, Hoa et al. 2007, Jean and Cyr 2007, Nichol et al. 2011, 
Wadhera et al. 2011). Some parents regard illness as a nutritional or chemical imbalance, 
and CAM is seen as a support for the body helping natural healing to occur (O´Keefe and 
Coat 2010). It also offers holistic care for the treatment of illnesses, not only concentration 
on a specific symptom (Simpson and Roman 2001, Nichol et al. 2011). 
Some parents think that CAMs are more effective than conventional therapies (Wadhera 
et al. 2011), and many parents have reported that CAM has been at least partially helpful 
for their child (Pitetti 2001, Simpson and Roman 2001, Lim et al. 2005, Zuzak et al. 2010, 
Wadhera et al. 2011). However, according to a cross-sectional survey, parents have 
considered CAM to be less effective than conventional medicines, but they think that in 
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certain cases it may also be more effective than conventional medicines (Zuzak et al. 2010). 
CAMs that have been reported to be helpful for children have included special diets, 
melatonin, megadoses of vitamins and massage (Huillet et al. 2011).  
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4 Summary of the Literature  
The most common symptoms experienced by children are symptoms of common cold, 
especially among young children under school age. In contrast, among school-aged 
children, different psychosomatic symptoms become prevalent and tend to increase with 
age. Among long-term diseases, allergy and asthma have been found to be the most 
common among children. Despite the common experience of different symptoms, children’s 
health is usually reported as being good by the parents. 
In families, it is usually the mother who detects and evaluates the child’s symptoms and 
makes the decision on the treatment chosen. For mild symptoms, the first course of action 
is usually to use home remedies and wait and see how the health of the child develops. Self-
medication is typically used for moderate symptoms, if the symptoms have lasted for a few 
days, and/or if there is no help from home remedies. Analgesics and antipyretics, especially 
paracetamol, are the most common OTC medicines used, while herbal medicines are the 
most common CAMs used. The main purpose of the use of CAM is especially to improve 
and maintain health. If the symptoms are severe, uncommon and/or self-medication does 
not help, a physician is usually consulted. 
Parental socioeconomic background was found to be associated with children’s health 
and also with the use of self-medication, especially CAMs. Low parental socioeconomic 
background was associated with poor health among children. In contrast, high parental 
socioeconomic background was found to predict the use of OTC medicines and CAMs. 
Parents also have various thoughts concerning medicine use for their children, which 
sometimes affect how they medicate their children with self-medication. Parental attitudes 
toward medicines are associated with the use of OTC medicines and CAMs; parental 
positive attitude toward medicines predicts the use of OTC medicines, and on the other 
hand, parental negative orientation and worry about medicine use predicts the use of CAMs 
for their children. 
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5 Aims of the Study 
The aim of this study was to explore the health of Finnish children under 12 years of age 
and the patterns of the use of self-medication, including OTC medicines and CAMs among 
them. 
 
The specific aims were to: 
 
1. determine children’s health, including the self-rated health reported by the parent, 
prevalence of long-term diseases and the experience of symptoms, 
 
2. assess how common the use of self-medication is among children and which types of 
self-medication are most commonly used, 
 
3. determine which factors, such as parental socioeconomic background and attitudes 
toward medicines, are associated with health and the use of self-medication among 
children. 
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6 Methods 
6.1 STUDY POPULATION AND DATA COLLECTION  
This survey was conducted in the spring (February−April) of 2007 as a postal survey by the 
School of Pharmacy, University of Eastern Finland. As a research method, postal survey 
was chosen in order to gain information on medicine use among children in a large sample. 
The study population consisted of a representative sample of 6,000 Finnish children under 
12 years of age, living in Finland in the end of 2006 (Figure 3). Children under this age were 
selected to the study population since the International Clinical Harmonization (ICH 2000) 
classifies children aged 2−11 years as children, and children over 11 years as adolescents. In 
addition, children older than 11 years of age became more independent in medicine use. 
The respondents should have been the children themselves if children older than 11 years 
of age had been included.  
The size of the study population was considered, in co-operation with a statistician, 
according to the previous population-based study in Finland (Klaukka et al. 1990) to have 
significant differences in the results when using age groups of 0−2, 3−6 and 7−11 if a response 
rate of 70% was gained (Figure 3). The study population was randomly selected from the 
database of the Finnish National Population Register Centre which covers information on 
everyone living permanently in Finland. Children in institutional care, under custody or 
those in situations with a restraining order of the parent were excluded from the study.  
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Figure 3. Data collection process.  
 
A 6-page questionnaire was sent to parents, primarily to the mothers, and it was directed to 
the parent who usually takes care of the child’s medication (Appendix 1, Appendix 2). The 
questionnaire was available in Finnish and Swedish, both of which are official languages in 
Finland. The child’s name was printed on the questionnaire to indicate which child in the 
family was included in the study sample. On return of the questionnaire, the name of the 
child was removed and replaced by a random number to ensure confidentiality. 
Two reminders were sent.  However, parents of eight children were not reached by mail, 
and thus the study sample consisted of 5,992 children. In total, 4,121 questionnaires were 
returned after the reminders. In 89 of the questionnaires, the parent had filled in information 
on behalf of a child who was not included in the initial study population, and these were 
excluded from the study population. Thus, the final study population included 4,032 
children, with a response rate of 67%. Most of the respondents (95%) were mothers. 
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6.2 CONTENT OF THE QUESTIONNAIRE  
The questionnaire consisted of the following sections: background information of the child 
(e.g. age, gender and current symptoms), the child’s medicine use, the information sources 
used about the child’s medication, and background information of the parent (e.g. medicine 
use by the parent and statements of parental attitudes toward medicines) (Appendix 2). 
Before sending the questionnaire, it was pilot-tested with a convenience sample of 61 
mothers, and minor modifications were made based on the pilot. The pilot-study also 
included a focus group discussion of a convenience sample of five mothers.  
6.2.1 Main outcome measures 
The main outcome measures of this study were child’s health (I) and the use of self-
medication; OTC medicine (II, IV) and CAM use by the child (II, III, IV, Table 2).  
 
Table 2. Description of the main outcome measures, background variables and statistical 
analyses used in different studies.  
 
 Main outcome measures Background variables Statistical 
analyses 
Study 
I 
• Child’s self-rated health 
reported by the parent 
• Current psychosomatic 
symptoms of a child 
• Current long-term disease of a 
child diagnosed by a physician 
• Socioeconomic status:  
- highest level of education of a parent   
- household net income/month (€)  
- working status of a parent 
• Pearson’s 
Chi-square-
test 
 
• Multivariate 
logistic 
regression 
analysis 
  • Adjusted for:  
 Child’s 
- age and gender 
- number of long-term diseases 
- presence of impairments  
- presence of other diseases  
- number of psychosomatic symptoms  
- number of other symptoms  
 
 
Study 
II 
• The current use of prescribed 
medicines 
• The use of self-medication: 
OTC medicines, vitamins and 
CAMs use in the preceding two 
days 
• Child’s  
- age and gender 
   
• Pearson’s 
Chi-square-
test 
 
 (Table 2. Continued) 
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Table 2. (Continued) 
 
 
Child’s health 
Child’s health was determined with self-rated health, the prevalence of long-term diseases 
and psychosomatic symptoms. Self-rated health was explored by asking the parent to report 
the current health status of the child on a 5-item Likert scale (good, fairly good, moderate, 
fairly poor or poor), and classified as “Good n=3,249”, “Fairly good n=631”, and “Moderate 
 Main outcome measures Background variables Statistical 
analyses 
Study 
III 
• The use of CAMs in the 
preceding two days 
• Child’s  
- age and gender 
- birth order 
- number of prescribed medicines 
used 
- number of OTC medicines used 
- number of vitamins used 
- health status 
- number of symptoms 
- number of doctor-diagnosed 
illnesses 
 
• Pearson’s 
Chi-square-
test 
 
• Multivariate 
logistic 
regression 
analysis 
 
  • Parent’s  
- age 
- highest level of education  
- households net income/month (€) 
- working status 
- number of prescribed medicines 
used 
- number of OTC medicines used 
- number of vitamins used 
- number of CAMs used 
 
 
Study 
IV 
• The use of OTC medicines and 
CAMs in the preceding two days 
 
• Parental attitudes toward medicines:  
- General attitude toward medicines 
- Attitude toward prescription 
- medicines 
- Attitude toward OTC medicines 
- Attitude toward the risks of 
medicines  
- Attitude toward the long-term use 
of pain-killers 
 
• Pearson’s 
Chi-square-
test 
 
• Univariate 
logistic 
regression 
analysis 
 
 
  • Adjusted for:  
  Child’s 
- age and gender 
- presence of doctor-diagnosed 
illnesses 
- number of symptoms  
- health status  
- number of children in the family 
 
  Parent’s 
- age 
- highest level of education  
- households net income/month (€) 
- working status 
- use of prescribed medicines  
- use of OTC medicines  
- use of CAMs  
• Multivariate 
logistic 
regression 
analysis 
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n=106, fairly poor n=25 and poor n=5” (Appendix 2). However, for the purpose of the 
analysis of study I, children’s self-rated health was classified as “Moderate or poor” 
(including moderate, fairly poor and poor), and as “Good” (including fairly good and good) 
to make a distinction between poor and good health as has been done in some other studies 
in this field (e.g. West and Sweeting 2004, Chen et al. 2006a, Chen et al. 2006b, Luopa et al. 
2008).   
The prevalence of long-term diseases was identified by asking the parent to report if the 
child had any diseases or injuries currently diagnosed by a physician (Appendix 2). Of the 
reported diseases, asthma, allergy, epilepsy, diabetes, lactose-intolerance, migraine, 
attention deficit hyperactivity disorder (ADHD), heart defect, atopy, rheumatoid arthritis, 
and coeliac disease were considered long-term diseases.  
The prevalence of psychosomatic symptoms was determined by presenting a list of 11 
symptoms and asking a parent to circle “Yes” or “No” depending on whether the child had 
any of these symptoms currently, i.e. at the moment when answering the questionnaire 
(Appendix 2). There was also a possibility to answer “Don’t know” or to report other 
symptoms not presented in the list. In the symptoms list, the following symptoms were 
classified as psychosomatic symptoms: sleep disorders, fatigue or dizziness, anxiety and 
depression.  
 
Use of self-medication 
The use of self-medication was determined by instructing the parent to write down the 
names of any OTC medicines given to their child, including vitamin products, in the 
preceding two days (Appendix 2). In a similar way, the use of CAMs was measured by 
asking the parent to report the names of medicinal herbs, botanicals or homeopathic 
remedies that the child had used in the preceding two days. The short recall period of two 
days was chosen in order to limit recall bias and to get comparable results with a previous 
population-based study in Finland (Arinen et al. 1998).  
 
6.2.2 Background variables 
 
Parental socioeconomic background 
Parental socioeconomic status was measured by asking the parent to report the highest 
education level from a 7-item list and household net income/month from an 11-item list 
(Appendix 2). The highest education of parent was classified as Junior high school or less 
(≤9 years), Senior high school/vocational school (11−13 years), Polytechnic, College or 
university degree (≥15 years). In addition, the following categories were formed of the 
household monthly net income/month: below €1,999, €2,000−2,999, €3,000−3,999 and 
€4,000−10,000. Working status of the parent was classified as “Working” and “Not in work” 
in studies I and III. Class “Not in work” included parents who were unemployed, at home 
with children, retired, studying, or on sick leave. In study IV, working status of a parent 
was classified as “Working or studying”, “Home with children”, and “Not in work” 
(including persons on sick leave and retired or unemployed persons).   
 
Parental attitudes  
Parental attitudes toward medicines were measured by a 21-item list of statements 
concerning medicine use in general and giving medicines to a child (Appendix 2). The 
attitudinal scale was created by the researchers on the basis of previous research results and 
it is described elsewhere (Hämeen-Anttila et al. 2011). Dimensions concerning parental 
attitudes toward medicines were discovered in the pilot focus group discussion; as a result, 
it was assessed whether the statements covered these dimensions. 
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Based on the focus group discussion, the statement “interactions between medicines 
worry me” was added to the statement list.  
Parents were directed to answer the statements according to a 6-item Likert scale (1=I 
disagree completely, 2=I disagree, 3=I don’t agree or disagree, 4=I agree, 5=I agree 
completely, or 0=no opinion). A Principal Components Analysis with oblimin rotation, 
which is described elsewhere (Hämeen-Anttila et al. 2011), was used to discover dimensions 
in parental attitudes. Based on the analysis, five principal components were formed 
(including 18 statements) (Table 3). The principal components were named as follows: 
“General attitude toward medicines”, “Attitude toward prescription medicines”, “Attitude 
toward OTC medicines”, “Attitude toward the risks of medicines”, and “Attitude toward 
the long-term use of pain-killers”. The reliability of the Principal Component Analysis was 
satisfactory (Cronbach’s alpha between 0.566 and 0.754).   
 
Table 3. The five principal components of parental attitudes and the statements they include 
(Hämeen-Anttila et al. 2011). 
 
Component 
Component 1: general attitude toward medicine 
 Fever, a natural means of defence of the child’s body, should not be lowered artificially with medicines 
 The child needs to learn how to bear pain 
 I try to take care of my child’s ailments by some other means than using medicines 
 I try to avoid giving medicines to my child 
 I usually give less analgesics to the child than recommended in the instructions 
 Medicines can disturb the body’s own capability to heal illnesses 
 Medicines are unnatural to the human body 
Component 2: attitude toward prescription medicines 
 Prescription medicines are effective 
 Prescription medicines are safe 
 Medicines that a doctor has prescribed for the child are necessary 
 Medicines are necessary in treating illnesses 
Component 3: attitude toward OTC medicines 
 OTC medicines are effective 
 I take care of my child’s minor ailments by using OTC medicines 
 Over-the-counter (OTC) medicines are safe 
Component 4: attitude toward the risks of medicines 
 Interactions between medicines worry me 
 Side effects of children’s medicines worry me 
Component 5: attitude toward the long-term use of pain-killers 
 Long-term use of analgesics reduces the pain threshold 
 The more you need to use analgesics the less effective they are against pain 
 
Scale scores were created by computing the averages of the original responses to the items 
in each scale, and they were afterwards categorized into three classes as follows. Scale score 
values 1−2.4 were defined as ”Negative regard”, 2.5−3.4 as ”Neutral regard”, 3.5−5 as 
”Positive regard” in terms of Attitude toward prescription medicines and Attitude toward 
OTC medicines. For General attitude toward medicines, Attitude toward the risks of 
medicines, and Attitude toward the long-term use of pain killers, scale score values 1−2.4 
were defined as ”Positive regard”, 2.5−3.4 as ”Neutral regard”, and 3.5−5 as ”Negative 
regard”. Consequently, positive regard actually indicates positive and negative regard 
indicates negative.  
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6.3 CLASSIFICATION OF SELF-MEDICATION  
Over-the-counter medicines 
OTC medicines, including registered vitamins, were coded according to their Anatomical-
Therapeutic-Chemical (ATC) classification system in 2007 (National Agency for Medicines 
2007). If the parent had reported the name of the product, it was coded according to the 
chemical substance. If the trade name of the product was not reported by the parent, the 
product was coded according to the closest level that was possible. 
 
Complementary and alternative medicines  
The reported CAM products were mainly classified according to the content of the product 
as probiotics, fish oils and fatty acids, homeopathics and other CAMs that included products 
for constipation and stomach function and preparations for cold, for example (Table 4). The 
use of non-registered vitamins was combined with registered vitamins, and reported in the 
results of study II. 
 
Table 4. The classification of Complementary and alternative medicines (CAMs). 
 
CAM product The number of reported 
products 
Per cent of  
cases 
Probiotics 142 16.7 
Fish oils and fatty acids 228 26.8 
Homeopathics 48 5.6 
Other CAMs 114 13.4 
 Preparations for a cold 20 2.3 
 Preparations for warts 7 0.8 
 Preparations for muscle pains 2 0.2 
 Other ointments 20 2.3 
 Xylitol preparations 7 0.8 
 Preparations for constipation and stomach
 function 
4 0.5 
 Other* 54 6.3 
*ginger preparations, preparations for dieting 
6.4 STATISTICAL ANALYSIS  
The data were analysed with Statistical Package for Social Sciences for Windows, Version 
14.0 and 17.0 (SPSS Inc., Chicago, IL, USA). To describe the results, frequencies, percentages, 
Pearson’s Chi-square -test (I, II, III, IV) and univariate logistic regression model (IV) were 
used. P-values of less than 0.05 were considered statistically significant. As a multivariate 
analysis, logistic regression model was used to determine factors associated with children’s 
health and self-medication (I, III, IV). The discriminating ability of the analysis was 
measured by receiver operating characteristic (ROC) curve analysis in each of these studies.  
6.5 ETHICS OF THE STUDY  
The study setting and research process was in accordance with the local and national ethical 
instructions for research (National Advisory Board on Ethics: 
http://www.tenk.fi/en/index.html). No ethical approval from the ethical review board was 
required for a postal survey. The questionnaire was addressed to either parent of the 
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children and since answering the questionnaire was voluntary, returning a questionnaire 
was seen as an informed consent from the parent. 
6.6 REPRESENTATIVENESS OF THE STUDY POPULATION  
The representativeness of the respondents and non-respondents was analysed and 
compared with the target population (II). The analysis showed that the study sample was 
representative of the target population regarding age and gender of the child. Minor 
differences were found in the regional distribution: Southern, 40.7% (the actual proportion 
of the children in that area is 41.1%); Western, 32.6% (34.9%); Eastern, 12.8% (9.9%); Oulu 
region, 10.1% (10.4%); Lapland, 3.4% (3.3%); and Åland 0.5% (0.5%). On the other hand, 
analysis of the non-respondents showed no significant differences compared with the target 
population in terms of age, sex, or regional distribution. 
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7 Results 
7.1 HEALTH AND THE USE OF SELF-MEDICATION AMONG CHILDREN (I, 
II, III) 
7.1.1 Health of children (I) 
The majority (97%) of children had good health status reported by their parent (I, Table 5). 
However, 11% of children had some long-term disease, and 66% of children had 
experienced some symptom. Approximately one third of the children had experienced one 
and one third two or more symptoms (data not shown). Psychosomatic symptoms had been 
experienced by 11% of children (I, Table 5).  
 
Table 5. Self-reported health among Finnish children under 12 years of age and the prevalences 
of the three most common long-term diseases, reported symptoms and psychosomatic 
symptoms.  
 
 Age, years  
 0−2 3−6 7−11 Total p 
 % (n) % (n) % (n) % (n)  
Health status 
(n=4,015) 
    <0.05 
Good 94 (932) 98 (1,256) 98 (1,692) 97 (3,880)  
Moderate or poor 6 (65) 2 (28) 2 (42) 3 (135)  
      
The prevalence of 
long-term diseases 
(n=4,009) 
9 (93) 10 (131) 13 (232) 11 (456) 0.002 
Allergy 3 (31) 3 (42) 5 (93) 4 (166) 0.003 
Asthma 2 (23) 4 (52) 4 (77) 4 (152) 0.015 
Atopy 4 (39) 3 (44) 2 (34) 3 (117) 0.006 
      
The prevalence of all 
reported symptoms 
(n=3,985)* 
72 (723) 65 (824) 63 (1,085) 66 (2,632) <0.05 
Symptoms of common 
cold 
43 (434) 37 (464) 26 (446) 34 (1,344) <0.05 
Eczema 29 (291) 25 (313) 20 (344) 24 (948) <0.05 
Flatulence 12 (115) 8 (101) 14 (238) 11 (454) <0.05 
      
The prevalence of 
psychosomatic 
symptoms 
(n=3,984)* 
13 (133) 8 (97) 12 (207) 11 (437) <0.05 
Sleep disorders 10 (104) 4 (49) 4 (65) 6 (218) <0.05 
Fatigue or dizziness 5 (45) 3 (40) 7 (111) 5 (196) <0.05 
Anxiety 1 (10) 2 (24) 5 (80) 3 (114) <0.05 
*at the moment when answering the questionnaire 
 
Good health status was most commonly reported for children aged over 2 years (98% of 
children aged 3−6 and 7−11 years) (I, Table 5). Children in these older age groups had also 
most commonly some long-term disease (10% and 13%, respectively). In contrast, the 
experience of symptoms was most prevalent among children under three years of age (72% 
of children at this age) compared to older ones. The prevalence of psychosomatic symptoms 
28 
 
was more common among children under three years of age (13% of children at this age) 
and 7- to 11-year-old children (12%) than among 3- to 6-year-old children. Child’s gender 
was not significantly associated with any of these health variables (I).  
The most common long-term diseases among children were allergy (4% of children) and 
asthma (4%) (I, Table 5). Having an allergy was most prevalent among children aged 7 to 11 
years (5% of the children in this age group), whereas asthma was equally common among 
children 3 to 6 years of age and 7 to 11 years of age (4%). 
Symptoms of common cold (34% of children) and eczema (24%) were the most common 
symptoms children had experienced at the time of answering the questionnaire (I, Table 5). 
Both of these symptoms were more prevalent among children under 3 years of age (43% for 
symptoms of cold and 29% for eczema) than among older children.  
Of psychosomatic symptoms, sleep disorders (6% of children) and fatigue or dizziness 
(5%) were the most common symptoms children had experienced (I, Table 5). Sleep 
disorders had most commonly been experienced by children under three years of age (10%), 
whereas fatigue or dizziness were most prevalent among the oldest children (7% of 7- to 11-
year-old children). 
7.1.2 The use of self-medication (II, III) 
In total, 50% of the children had used some self-medication, OTC medicines, vitamins, 
and/or CAMs (II, Table 6). One fifth of the children had used some OTC medicines 
(excluding vitamins) and one tenth some CAM (excluding vitamin use) (II, III, Table 6). The 
majority of the CAM users had used CAM in conjunction with OTC and/or prescribed 
medicines (7% of children), and three per cent of children had used only some CAM (III).  
 
Table 6. The overall use of self-medication, and the proportions of users of OTC medicines and 
CAMs in the preceding two days among Finnish children under 12 years of age.  
 
 Overall use of self-
medication† 
Proportion of OTC 
medicine users* 
Proportion of CAM 
users‡ 
 % (n) % (n) % (n) 
Age, years p<0.05 p<0.05 p=0.08 
0−2 73 (723) 24 (232) 12 (121) 
3−6 48 (606) 16 (202) 10 (124) 
7−11 39 (662) 13 (221) 12 (207) 
Gender p=0.39 p=0.51 p=0.14 
Boy 49 (1028) 16 (335) 12 (251) 
Girl 51 (963) 17 (320) 11 (201) 
Total 50 (1,991/3,986) 17 (655/3,942) 11 (452/3,958) 
†use of OTC medicines, vitamins and/or CAMs  *also other types of self-medication (CAMs, vitamins) 
may be in use ‡also other types of self-medication (OTC medicines, vitamins) may be in use 
 
The overall use of self-medication and the use of OTC medicines were most common among 
children under 3 years of age; 73% of children of this age had used some self-medication, 
and the figure for the use of OTC medicines in this age group was 24% (II, Table 6). No 
differences were seen in the use of CAMs according to different ages (II, III, Table 6). In 
contrast, the use of only CAMs was most common among children aged 7 to 11 years (5%), 
and the complementary use of CAMs among children aged under three (11%) (III). Child’s 
gender was not significantly associated with any of these variables (II, III, Table 6). 
Analgesics and antipyretics, including non-steroidal anti-inflammatory (NSAIDs) drugs 
were the most commonly used OTC medicines among children (7%), followed by cough 
and cold preparations (2% of children) (II, Table 7). Paracetamol was the most common 
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analgesic and antipyretic the children had used in the preceding two days (II). The use of 
analgesics and antipyretics, including NSAIDs, was most common among children under 
three years of age (9% of children of this age) (II, Table 7). 
 
Table 7. Three most commonly used OTC medicines and CAMs among Finnish children under 12 
years of age in the preceding two days. 
 
 Age, years  
 0−2  
(n=966) 
3−6 
(n=1,252) 
7−11 
(n=1,674) 
Total 
(n=3,892*) 
p 
 % (n) % (n) % (n) % (n)  
OTC medicines      
Analgesics and 
antipyretics, 
including NSAIDs 
9 (91) 5 (59) 7 (109) 7 (259) <0.05 
Cough and cold 
medicines 
2 (18) 4 (45) 2 (29) 2 (92) 0.002 
Preparations for 
treatment of wounds 
and ulcers 
4 (39) 2 (30) 1 (18) 2 (87) <0.05 
CAMs      
Fish oils and fatty 
acids 
2 (15) 5 (63) 8 (135) 6 (213) <0.05 
Probiotics 8 (75) 3 (42) 1 (23) 4 (140) <0.05 
Homeopathics 1 (10) 1 (10) 1 (11) 1 (31) 0.58 
*Study population consists of children that had no missing data on any of the questions of prescription 
medicines, OTC medicines and CAMs use 
 
Of CAMs, the children had most commonly used fish oils and fatty acids (6%) and probiotics 
(4%) (II, III, Table 7). Homeopathics had been used by 1% of the children. The use of fish oils 
and fatty acids was most common among children aged 7 to 11 years, whereas the use of 
probiotics was most common among children under 3 years of age (II, Table 7).  
7.2 FACTORS ASSOCIATED WITH HEALTH AND THE USE OF SELF-
MEDICATION AMONG CHILDREN (I, III, IV)  
7.2.1 Parental socioeconomic background (I, IV) 
The association of parental socioeconomic background was explored with regard to 
children’s health (I, Table 8) and the use of OTC medicines and CAMs (IV, Table 9). No 
significant association was found between parental socioeconomic background and 
children’s health (self-rated health, the prevalence of long-term diseases or the prevalence 
of psychosomatic symptoms), OTC medicines or CAM use among children (I, Table 8, Table 
9).  
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Table 8. A multivariate logistic regression analysis of factors associated with children’s health 
(n=4032). 
 
 Poor health status Psychosomatic 
symptoms 
Long-term 
diseases 
 OR (95%CI) OR (95%CI) OR (95%CI) 
Child’s    
Gender p=0.61 p=0.42 p=0.05 
 Girl 1.00 1.00 1.00 
 Boy 0.90 (0.59−1.37) 0.92 (0.74−1.14) 1.23 (1.00−1.51) 
Age, years p<0.05 p<0.05 p<0.05 
 0−2 1.00 1.00 1.00 
 3−6 0.35 (0.20−0.61) 0.53 (0.39−0.72) 1.22 (0.90−1.66) 
 7−11 0.33 (0.20−0.57) 0.93 (0.71−1.23) 1.67 (1.24−2.23) 
Number of long-term 
diseases 
p<0.05 p<0.05 - 
 0 1.00 1.00 - 
 1 1.48 (0.83−2.63) 1.62 (1.19−2.22) - 
 ≥2 5.51 (2.53−12.0) 1.62 (0.92−2.85) - 
Presence of impairments* p=0.01 p<0.05 p=0.05 
 0 1.00 1.00 1.00 
 1 3.17 (1.26−7.98) 2.27 (1.31−3.95) 1.76 (1.01−3.06) 
Presence of other diseases* p<0.05 p<0.05 p=0.64 
 0 1.00 1.00 1.00 
 1 9.39 (5.94−14.85) 1.65 (1.16−2.33) 0.91 (0.61−1.35) 
Number of psychosomatic 
symptoms 
p<0.05 - p<0.05 
 0 1.00 - 1.00 
 1 4.50 (2.78−7.27) - 1.64 (1.20−2.25) 
 ≥2 8.51 (4.47−16.23) - 1.44 (0.85−2.43) 
Number of other 
symptoms* 
p<0.05 p<0.05 p<0.05 
 0 1.00 1.00 1.00 
 1 3.19 (1.18−8.63) 1.78 (1.29−2.47) 2.00 (1.50−2.67) 
 2 6.34 (2.37−16.96) 3.30 (2.35−4.64) 2.72 (1.98−3.73) 
 ≥3 12.53 (4.81−32.66) 7.70 (5.53−10.73) 4.06 (2.93−5.64) 
Parent’s    
Highest level of Education p=0.61 p=0.80 p=0.05 
 Polytechnic, college, or   
 university degree (≥15 
 years)  
1.00 1.00 1.00 
 Senior high 
 school/vocational school 
 (11−13 years) 
1.23 (0.76−1.98) 1.07 (0.83−1.37) 0.78 (0.62−0.98) 
 Junior high school or less 
 (≤9years) 
0.89 (0.32−2.50) 1.16 (0.72−1.85) 0.63 (0.38−1.04) 
Working status p=0.27 p=0.11 p=0.28 
 Working 1.00 1.00 1.00 
 Not in work 0.77 (0.48−1.22) 1.22 (0.96−1.56) 0.88 (0.69−1.12) 
Monthly net income of the 
household in euros 
p=0.36 p=0.35 p=0.59 
 4,000−10,000 1.00 1.00 1.00 
 3,000−3,999 0.88 (0.38−2.06) 0.78 (0.52−1.19) 1.26 (0.85−1.86) 
 2,000−2,999 1.32 (0.57−3.10) 0.97(0.63−1.48) 1.12 (0.74−1.69) 
 ≤1,999 1.42 (0.58−3.49) 0.98 (0.62−1.54) 1.25 (0.81−1.94) 
*described in study I 
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Table 9. A multivariate logistic regression analysis of factors associated with children’s use of 
OTC medicines and CAMs (n=4032). 
 
  The use of OTC 
medicines by children 
 The use of CAMs  
by children 
  OR (95%CI)  OR (95%CI) 
Child’s     
Gender  p=0.52  p=0.16 
 Girl  1.00  1.00 
 Boy  0.94 (0.78−1.14)  1.17 (0.94−1.47) 
Age, years  p<0.05  p=0.24 
 0−2  1.00  1.00 
 3−6  0.66 (0.51−0.86)  0.84 (0.60−1.17) 
 7−11  0.48 (0.36−0.63)  1.05 (0.74−1.49) 
Presence of doctor-diagnosed illnesses  p=0.005  p=0.09 
 No  1.00  1.00 
 Yes  0.70 (0.54−0.90)  1.28 (0.96−1.71) 
Number of symptoms   p<0.05  p<0.05 
 0  1.00  1.00 
 1  2.82 (2.07−3.83)  1.33 (0.98−1.80) 
 ≥2  6.54 (4.84−8.84)  1.88 (1.39−2.55) 
Health status reported by the parent  p<0.05  p=0.51 
 Good   1.00  1.00 
 Fairly good  1.87 (1.47−2.37)  1.15 (0.85−1.56) 
 Moderate, fairly poor or poor  2.53 (1.63−3.92)  1.30 (0.75−2.28) 
Number of children in the family  p=0.60  p=0.02 
 1  1.00  1.00 
 2   1.02 (0.78−1.34)  0.81 (0.59−1.11) 
 ≥3  0.91 (0.68−1.22)  0.62 (0.44−0.88) 
Parent’s     
Prescribed medicine use   p=0.41  p=0.15 
 No  1.00  1.00 
 Yes  1.09 (0.89−1.32)  0.84 (0.66−1.06) 
OTC medicine use   p=0.02  p=0.43  
 No  1.00  1.00 
 Yes  1.27 (1.04−1.55)  1.11 (0.87−1.41) 
CAM use   p=0.29  p<0.05 
 No  1.00  1.00 
 Yes  1.14 (0.90−1.45)  7.25 (5.75−9.13) 
Parental age, years  p=0.13  p=0.78 
 ≤30  1.00  1.00 
 31−45  1.30 (1.01−1.68)  1.09 (0.79−1.49) 
 ≥46  1.34 (0.79−2.28)  1.21 (0.70−2.11) 
Highest level of education  P=0.57  p=0.07 
 Junior high school or less (≤9years)  1.00  1.00 
 Senior high school/vocational school  
 (11−13 years) 
 1.06 (0.70−1.62)  1.45 (0.79−2.64) 
 Polytechnic, college, or university 
 degree (≥15 years) 
 0.95 (0.60−1.49)  1.82 (0.97−3.40) 
Working status  p=0.72  p=0.07 
 Not working (including persons on sick 
 leave, retired, or unemployed) 
 1.00  1.00 
 Working or studying  0.84 (0.54−1.30)  1.56 (0.85−2.87) 
 Home with children  0.86 (0.54−1.37)  1.97 (1.04−3.73) 
Monthly net income of the household in 
euros 
 p=0.88  p=0.51 
 ≤1,999  1.00  1.00 
 2,000−2,999  1.03 (0.79−1.34)  0.94 (0.68−1.31) 
 3,000−3,999  0.93 (0.71−1.24)  1.13 (0.81−1.57) 
 4,000−10,000  1.01 (0.67−1.53)  1.24 (0.77−1.98) 
 (Table 9. continued) 
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Table 9. (continued). 
 
 The users of OTC 
medicines by children 
 The users of CAMs  
by children 
 OR (95%CI)  OR (95%CI) 
General attitude toward medicine: p=0.19  p=0.86 
 Negative regard 1.00  1.00 
 Neutral regard 1.23 (0.91−1.67)  0.92 (0.67−1.27) 
 Positive regard 1.36 (0.98−1.91)  0.96 (0.66−1.38) 
Attitude toward prescription 
medicines: 
p=0.10  p<0.001 
 Negative regard 1.00  1.00 
 Neutral regard 2.68 (0.89−8.09)  0.46 (0.23−0.92) 
 Positive regard 3.03 (1.03−8.98)  0.24 (0.12−0.46) 
Attitude toward OTC medicines: p=0.04  p=0.02 
 Negative regard 1.00  1.00 
 Neutral regard 1.00 (0.71−1.40)  1.49 (0.97−2.30) 
 Positive regard 1.28 (0.93−1.78)  1.78 (1.16−2.72) 
Attitude toward the risks 
medicines: 
p=0.61  p=0.01 
 Negative regard 1.00  1.00 
 Neutral regard 1.03 (0.82−1.31)  0.82 (0.61−1.10) 
 Positive regard 1.20 (0.84−1.73)  0.43 (0.24−0.77) 
Attitude toward the long-term use 
of pain-killers: 
p=0.76  p=0.72 
 Negative regard 1.00  1.00 
 Neutral regard 1.03 (0.83−1.29)  1.08 (0.83−1.39) 
 Positive regard 0.93 (0.70−1.23)  1.14 (0.82−1.58) 
7.2.2 Parental attitudes (IV) 
The association of parental attitudes toward medicines and the use of OTC medicines and 
CAMs among children were assessed in study IV. The results are also presented in Table 9. 
Of parental attitudes, only the attitude toward OTC medicines was associated with the 
use of OTC medicines among children (p=0.04) (IV, Table 9). However, no specific 
differences were found between the categories of parental views toward OTC medicines 
and in the use of OTC medicines among children.  
In contrast, parental attitude toward prescription medicines, OTC medicines and the 
risks of medicines was significantly associated with the use of CAMs among children (IV, 
Table 9). Children whose parent had positive views toward prescription medicines were 
less likely to use CAM compared to children with parents having negative attitudes toward 
prescription medicines. In contrast, children whose parents had a positive regard toward 
OTC medicines were more likely to use CAMs compared to children with parents having 
negative views about OTC medicines.  Worries about the risks of medicines on the part of 
the parent also predicted the use of CAMs among children. 
7.2.3 Other factors (I, IV) 
Of other factors, age was found to be associated with children’s health; the probabilities for 
moderate or poor health status were lower among 3- to 6-year-old and 7- to 11-year-old 
children than among children aged 0 to 2 years, and for psychosomatic symptoms among 
3- to 6-year-old children (I, Table 8). In contrast, the probability of having a long-term 
disease was highest among children aged 7 to 11 years.  A number of different adverse 
health variables (e.g. number of long-term diseases, number of psychosomatic and other 
symptoms) were also associated with children’s poor health status, psychosomatic 
symptoms and the prevalence of long-term diseases among children. Especially an 
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increasing number of long-term and other diseases, psychosomatic and other symptoms 
predicted poor health status of children. 
Factors that were found to predict the use of OTC medicines among children were the 
young age of a child, child’s poor health status reported by the parent, the child having one 
or more symptoms, and parental use of OTC medicines (IV, Table 9). If the child had some 
illness diagnosed by a physician, the use of OTC medicines was less likely than among 
children with no diseases diagnosed by a physician.  
On the other hand, parental use of CAMs, illness diagnosed by a physician, and the child 
having one or more symptoms predicted the use of CAMs among children (IV, Table 9). In 
addition, if there were three or more children in the family, the use of CAMs was less likely 
than among children in families with one child.  
7.3 SUMMARY OF THE RESULTS  
The health of Finnish children was most commonly reported to be good by the parents 
(Figure 4). One tenth of the children had some long-term disease, and over half of them had 
experienced some symptom(s) currently. The prevalence of psychosomatic symptoms was 
11%. Allergy and asthma were the most common long-term diseases, and symptoms of 
common cold and eczema the most common symptoms children had experienced at the 
time when answering the questionnaire. Of psychosomatic symptoms, sleep disturbances 
and fatigue or dizziness were most common ones experienced by the children. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Results of the study applied to the self-care process among Finnish children. 
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In total, half of the children had used some self-medication (Figure 4). The proportion of 
users of OTC medicines and CAMs was 17% and 11%, respectively. The most commonly 
used OTC medicines among children were analgesics and antipyretics, including NSAIDs, 
mainly paracetamol. Fish oils and fatty acids and probiotics were the most commonly used 
CAM products among children.  
The number of various symptoms and diseases was found especially to be associated 
with poor health of the child. In contrast, poor health of a child and parental own use of self-
medication was associated with the use of self-medication among children (Figure 5). No 
significant differences were found between parental socioeconomic background and 
children’s health or the use of self-medication. Parental attitudes toward medicines were 
found to be associated with the use of self-medication among children, and especially with 
the use of CAMs. Children whose parent had positive views toward prescription medicines 
were less likely to use CAMs compared to children with parents having a negative regard 
toward prescription medicines. In contrast, parental positive regard toward OTC medicines, 
and on the other hand, worries about the risks of medicines, predicted the use of CAMs 
among children.  
Figure 5. Factor’s related to children’s health and the use of self-medication (OTC medicines and 
CAMs) according to the results of this study.  
Health 
(Self-rated health, prevalence's of 
long-term diseases and 
psychosomatic symptoms)
•Increase
•Increasing number of long-term 
diseases, presence of impairments, 
other diseases, psychosomatic and 
other symptoms were associated with 
poor health status of a child and the 
experience of psychosomatic 
symptoms
•Older age of a child, having one 
psychosomatic symptom and 
increasing number of other symptoms 
were associated with the prevalence 
of long-term diseases
•Decrease
•The prevalence of poor health status 
was lowest among children older than 
2 years of age
•The prevalence of psychosomatic 
symptoms was lowest among 3- to 6-
year-old children
•No significant association
•Parental socioeconomic background
OTC medicines use
•Increase:
•Young age of a child
•Increasing number of symptoms
•Poor health status of a child
•Parental use of OTC medicines
•Decrease
•Doctor-diagnosed illness
•No significant association
•Parental socioeconomic background
CAMs use
•Increase
•Increasing number of symptoms
•Doctor-diagnosed illness
•Parental use of CAMs
•Parental worries about the risks of 
medicines
•Parental positive attitude toward OTC 
medicines
•Decrease
•Increasing number of children in 
family
•Parental positive attitude toward 
prescription medicines
•No significant association
•Parental socioeconomic background
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8 Discussion 
8.1 CHILDREN’S HEALTH  
This study showed that the general health among Finnish children is good, as has also been 
found in previous studies (e.g. Office for National Statistics 2002, Rimpelä et al. 2004, 
Emerson et al. 2006, Johnson and Wang 2008, National Institute for Health and Welfare 
2012). One tenth of the children had some long-term disease. The prevalence of long-term 
diseases among children in Finland was significantly lower than in 1995/96, when 
approximately 20% of children under 15 years of age had some long-term disease (Arinen 
et al. 1998). However, the figures for adolescents (aged 12 to 18 years) during the years 1980 
and 2007 were similar as in this study, approximately 10% (Rimpelä et al. 2004, Luopa et al. 
2008).  
There are some differences in the measurement of long-term disease compared to 
previous studies from Finland and some studies abroad, which may explain the difference 
in the results. The prevalence of long-term diseases was measured according to the child’s 
current diseases diagnosed by a doctor, and the classification was made by the research 
group. In the previous study from Finland, the prevalence of long-term diseases was 
measured by asking a parent to report whether the child had some injury or current long-
term disease affecting his/her daily life (Arinen et al. 1998). The question was similar as was 
used for adolescents (Rimpelä et al. 2004, Luopa et al. 2008). Despite this similarity, the 
prevalences of long-term disease differed among children under 12 years of age and 
adolescents (Arinen et al. 1998, Rimpelä et al. 2004). In addition, some other previous studies 
from abroad have measured the prevalence of long-term diseases, for example, as an illness 
or disability that has lasted at least three months during the past year (Halldórsson et al. 
2000, Berntsson and Köhler 2001, Reinhardt Pedersen and Madsen 2002). Thus, these 
previous studies may also include different disabilities, which were not included in our 
definition, but exclude newly diagnosed long-term diseases, which could be reported in our 
study. However, in spite of this difference in the methods used the results that allergy and 
eczema were the most common long-term diseases among children were consistent with 
previous findings (Arinen et al. 1998, Takala et al. 2001, Victorino et al. 2009).  
The majority (66%) of the children had currently, i.e. at the moment when answering the 
questionnaire, experienced some symptom(s), mostly symptoms of common cold and 
eczema. Psychosomatic symptoms had been experienced by 11% of the children. Our results 
were not in accordance with the previous findings that the prevalences of psychosomatic 
symptoms increase with age (Halldórsson et al. 2000, Haugland et al. 2001, Reinhardt 
Pedersen and Madsen 2002, Petersen et al. 2003, Emerson et al. 2006, Ishida et al. 2012). In 
our study, sleep disorders were the most common symptoms the children had experienced, 
especially among children under three years. In many previous studies that have included 
sleep disorders as psychosomatic symptoms, only children aged two years and/or over have 
been included in the study population (Halldórsson et al. 2000, Berntsson and Köhler 2001, 
Haugland et al. 2001, Reinhardt Pedersen and Madsen 2002, West and Sweeting 2004). In 
addition, the definitions of psychosomatic symptoms also vary between different studies. 
Some of the studies have included different pains, such as stomach ache and headache, as 
psychosomatic symptoms (Halldórsson et al. 2000, Berntsson and Köhler 2001, Reinhardt 
Pedersen and Madsen 2002), which tend to be more common among older children and 
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adolescents (Halldórsson et al. 2000, Haugland et al. 2001, Reinhardt Pedersen and Madsen 
2002, Petersen et al. 2003, Emerson et al. 2006, Uijen et al. 2008). In this study, symptoms of 
pains were not regarded as psychosomatic symptoms.  
8.1.1 Factors associated with children’s health 
The results indicated that adverse health variables have a cumulative effect on children’s 
health. Children who had poor health status reported by their parent, some long-term 
disease or had experienced of some psychosomatic symptoms, also had some other health 
burden currently, such as other symptoms, diseases and/or impairments. 
In contrast, parental socioeconomic factors were not found to be associated with 
children’s health in this study. This was in contrast to previous findings of parental socio-
economic background being a predictive factor especially for poor health in children (e.g. 
Halldórsson et al. 2000, West and Sweeting 2004, Bauman et al. 2006, Chen et al. 2006a, 
Currie and Lin 2007, Johnson and Wang 2008, Victorino and Gauthier 2009). In an older 
Finnish study, a slight significant association was seen between mother’s education and 
children’s health in 1996; children with lower educated mothers had fewer diseases than 
children with higher educated mothers (Takala et al. 2001). This was seen also in the case of 
asthma and allergies. It was speculated that a child with a higher educated mother may 
possibly be taken earlier to see a physician than a child with a lower educated mother. 
Having private insurance also increased the possibility for some diseases, especially asthma 
and allergy (Takala et al. 2001). A private insurance might make it easier to contact medical 
services (Duderstadt et al. 2006), and families with higher educated parents may have better 
possibilities to acquire insurance for their child. In this study, we do not know whether or 
not the child was covered by private insurance. 
It is difficult to estimate the main reasons for the differences in the results of present and 
previous studies. Reasons may possibly be found from the definition of socioeconomic 
background, age of the study population and/or socioeconomic background of the parents. 
Education level and/or income have been widely used indicators of socioeconomic status 
also in previous studies (e.g. Halldórsson et al. 2000, Berntsson and Köhler 2001, Bauman et 
al. 2006, Chen et al. 2006b, von Rueden et al. 2006, Larson et al. 2008, Victorino and Gauthier 
2009), of which the classification of education level, especially, is mainly comparable with 
these previous studies (e.g. Halldórsson et al. 2000, Berntsson and Köhler 2001, Bauman et 
al. 2006, Victorino and Gauthier 2009).  However, there were some differences in the age of 
the study populations. Most of the previous studies have also included adolescents, children 
aged under 18 years, as one homogenous group in their study population (e.g. Berntsson 
and Köhler 2001, Bauman et al. 2006, Chen et al. 2006a, Larson et al. 2008, Victorino and 
Gauthier 2009), which may indicate that parental socioeconomic background is a more 
predictive factor for children’s health in adolescence than in childhood.  
The parents in our study were quite well educated, which may be one reason for the 
distinction in the results. When comparing the education level of the respondents (mothers) 
to the education level of all women in Finland, it may be seen that the respondents in our 
study were slightly more highly educated than women over 14 years of age on average in 
2007 (Statistics Finland 2012). Around one third (32%) of the respondents had a polytechnic, 
college or university degree (≥15 years), whereas the proportion of women with some 
tertiary education was 29% in 2007 (and 26% among all citizens). In addition, it has also been 
explored previously that non-respondents are usually people with low socioeconomic 
background (Halldórsson et al. 2002, Tolonen 2005, Slone Epidemiology Center 2006, 
Trajanovska et al. 2010b). However, the socioeconomic status of non-respondents could not 
be identified in this study.  
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Even though no differences were seen between parental socioeconomic background and 
childhood health variables in this study, socioeconomic differences in health can also be 
observed in Finland, despite the fact that the overall health of people has improved during 
the last decades (Arinen et al. 1998, Palosuo et al. 2007, Lahelma et al. 2007, Ministry of Social 
Affairs and Health 2012). Socioeconomic differences in health have increased especially in 
mortality during the last decades (Palosuo et al. 2007), also among children (Remes 2012). 
Minimizing health inequalities between different population groups has also been one of 
the objectives for health policy in Finland since 1986 (Ministry of Social Affairs and Health 
2001, Palosuo et al. 2007, Ministry of Social Affairs and Health 2012).   
8.2 THE USE OF SELF-MEDICATION 
The results of this study highlighted that the role of self-medication in self-care among 
children has increased in Finland during the last decade (Arinen et al. 1998, Figure 6). The 
results also indicate that parents are more aware of using self-medication as symptom 
treatment, but also as a preventive measure and to maintain good health.  
 
 
Figure 6. The prevalences of OTC medicine and CAM use in the preceding two days among 
children in Finland in 1996 (children aged 0−6 and 7−14 years) and in 2007 (children aged 0−12 
years) (Arinen et al. 1998). 
 
A slight increase in the use of self-medication, especially analgesics use, has also been shown 
in Spain among children under 16 years of age (Carrasco-Garrido et al. 2009). The trend in 
CAM use has not been explored in previous studies among children abroad, but an 
increasing trend in CAM use has also been seen among adults in the USA and Italy, for 
example (Eisenberg et al. 1998, Menniti-Ippolito et al. 2002, Su and Li 2011).  
A reason for the increased use of self-medication might be the increased availability of 
OTC medicines and CAMs (WHO 1998, WHO 2000).  Increased education level among 
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citizens may also be one reason for the use (WHO 1998). People with higher education may 
have more interest in taking care of their own health, have better knowledge of medicines, 
and it has also been indicated that higher educated people have better health literacy than 
people with lower education (Calamusa et al. 2012). In addition, the use of different sources 
of information, such as health care professionals, books and package information leaflets 
has been found to be more common among parents with high education than among lower 
educated parents (grades 11 and over) (Jensen et al. 2010, Calamusa et al. 2012, Holappa et 
al. 2012).  
The current medicines policy of the Ministry of Social Affairs and Health in Finland 
(2011) states that the good availability of medicines should be kept in Finland in the future. 
One of the basics for this aim has been the extensive pharmacy network and its quality that 
covers the whole of Finland (Ministry of Social Affairs and Health in Finland 2011, Suomen 
Apteekkariliitto 2012, Suomen Apteekkariliitto 2013). Other aims expressed in the current 
medicines policy are to increase the status of self-medication and to increase the active role 
of consumers in their own self-care (Ministry of Social Affairs and Health 2011). On the other 
hand, pharmaceutical industry has proposed that more medicines should be switched from 
prescription status to OTC medicine status (Lääketeollisuus ry 2010, Lääketeollisuus ry 
2012, Association of the European self-medication industry (AESGP) 2013). Furthermore, 
The Finnish Grocery Trade Association has advocated that a restricted selection of some 
OTC medicines, e.g., analgesics and cough and cold medicines, should be available for 
consumers via grocery stores, as has been done in countries such as Norway, Denmark and 
Sweden (Anell 2005, Mankinen and Rantala 2009). Thus, the role of self-medication is under 
debate at the moment, but all quarters agree that the role of patients will increase. 
8.2.1 Factors associated with the use of self-medication  
  
Parental socioeconomic background 
No significant differences were found between parental socioeconomic background and 
children’s self-medication. Previously, the use of OTC medicines and CAMs had been found 
to be more common among children with a highly educated parent (e.g. Kogan et al. 1994, 
Ecklund and Ross 2001, Tobi et al. 2003, Crawford et al. 2006, Smith and Eckert 2006, Du 
and Knopf 2009b, Zuzak et al. 2009, Birdee et al. 2010). One reason for this distinction may 
be in the definition of OTC medicine and especially of CAM. Most of the previous studies 
have also included CAM therapies, such as acupuncture and chiropractic treatment, in their 
definition, which were excluded from our study (e.g. Menniti-Ippolito et al. 2002, Zuzak et 
al. 2009, Birdee et al. 2010). 
 
Parental attitudes 
The results showed that parental attitudes are related to the use of self-medication for their 
child. Worries about the adverse events, e.g. interactions of medicines were found to predict 
the use of CAMs among children. It has also been found in some previous studies that 
parents typically perceive CAMs as natural and safe (Crawford et al. 2006, Hoa et al. 2007, 
Jean and Cyr 2007, Nichol et al. 2011, Wadhera et al. 2011), and the fear of side-effects of 
conventional medicines, for example, has been one of the reasons for giving CAMs to 
children (Simpson and Roman 2001). If the parent felt the use of prescription medicines to 
be safe, the use of CAMs among children was less likely. CAM use among children was also 
more likely if the parent felt confident about using OTC medicines. Reasons for this result 
may be that the distinction between CAMs and OTC medicines may sometimes be unclear 
to parents (Furnham 2002) since most of the CAM products children had used are also sold 
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in pharmacies in Finland. Some of the CAMs used may also have been recommended by 
health care professionals, such as probiotics, which may be used for the treatment of 
infantile colic, for example (Savino et al 2007). These parents with a positive attitude toward 
OTC medicines may also be positively oriented toward self-medication overall. 
Even though a significant association between parental attitudes and the use of self-
medication was found, the results indicated that other factors, especially the experience of 
symptoms and parental use of self-medication, are more predictive factors for the use of 
self-medication among children than attitudes themselves. 
8.3 SAFE USE OF SELF-MEDICATION 
One aim of the current medicines policy of the Ministry of Social Affairs and Health in 
Finland (2011) is to increase availability of reliable sources of information about medicines 
for health care professionals and consumers and to ensure the safe use of medicines. This 
may be done by developing tools for safe use of self-medication with support from the 
health care professionals (Ministry of Social Affairs and Health 2011). One tool is to develop 
reliable sources of information about medicines for consumers and to improve the health 
literacy of the general public (Fimea 2012). Consumers’ possibility to gain reliable 
information about medicines would increase by improving the understandability of 
package information leaflets and gathering reliable links of the sources of information about 
medicines on the Internet.  
Earlier studies indicate that the improvement of information sources concerning self-
medication is needed, not only for OTC medicines, but for CAMs as well. Research shows 
that therapeutic errors do sometimes happen when medicines are administered for children 
at home (McD Taylor et al. 2009). Usual errors are connected with the dose, such as giving 
double the dose that has been recommended. However, in this study, the doses of OTC 
medicines or CAMs administered at home for children were not studied. 
Parents were found to feel safe in using CAMs for their child in this study and earlier, 
and to sometimes use them especially if they are worried about the adverse effects of 
conventional medicines (e.g. Simpson and Roman 2001, Menniti-Ippolito et al. 2002). In 
addition, according to a qualitative study, parents that had given CAM to their child had 
less knowledge about the possible harmful effects of CAM than the non-users of CAM (Araz 
and Bulbul 2011). It has also been found in this study and previously that the use of CAMs 
besides conventional care is quite common (Shaw et al. 2006, Laengler et al. 2008, Du and 
Knopf 2009b, Wood and Finlay 2011). This may increase the risk for interactions. In addition, 
parents do not always tell their child’s physician of the use of CAMs. According to different 
studies, approximately 33 to 53 per cent of the responding parents had reported CAM use 
to their child’s physician (Simpson and Roman 2001, Cincotta et al. 2006, Jean and Cyr 2007, 
Low et al. 2008, Zuzak et al. 2009, Huillet et al. 2011).  
The safe use of self-medication should be discussed with parents by health care 
professionals. As stated in the current medicines policy, attention should also be paid to the 
use of non-medicinal treatments, such as CAMs (Ministry of Social Affairs and Health in 
Finland 2011). Health care professionals should find out if CAMs are used in conjunction 
with conventional medicines. Information should be given to parents that also CAMs may 
have some risks. By giving reliable information to parents about self-medication it could 
also be possible to affect their attitudes toward self-medication and to avoid risks that may 
occur with complementary use of medicines and CAMs. 
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8.4 METHODOLOGICAL CONSIDERATIONS  
Questionnaire as a survey method was selected since it is an easy and rapid way to gain 
representative information about a large population that cannot be obtained from registers, 
for example (Turunen 2008). The response rate in this study was 67%, which may be 
considered as good for a questionnaire survey (Tolonen 2005). Such high response rates 
varying 61% to 92% have also been obtained in other studies concerning self-medication 
among children (e.g. Arinen et al. 1998, Madsen et al. 2003, Smith and Eckert 2006, Barnes 
et al. 2008, Du and Knopf 2009a, Vernacchio et al. 2009, Zuzak et al. 2010), which indicates 
parental interest in this subject. The analysis of the representativeness showed the study 
population to be representative of the target population according to age and gender. Minor 
differences were seen in the regional distribution of children.  
Despite the good response rate gained, there might be differences in health and the use 
of self-medication between the respondents and non-respondents. Since the non-
respondents have usually lower socioeconomic background than the respondents 
(Halldórsson et al. 2002, Tolonen 2005, Slone Epidemiology Center 2006, Trajanovska et al. 
2010b), it is possible that these children have also worse health status and more medicines 
in use than the respondents. In addition, since the socioeconomic differences are increasing 
in Finland it is apparent that also the differences in health will increase. Via maternity 
clinics, for example, it could be possible to explore the differences in health and in the 
medicine use of children with different socioeconomic backgrounds, since they are served 
all families free of charge. 
The health measures described the children’s health status, long-term diseases and the 
experience of symptoms. Since the current health of the children was identified, the 
questions were not very vulnerable to recall bias. The proportions of parents that answered 
these questions were high, with only 0.4% missing cases for self-rated health, 0.6% for long-
term diseases, and 1.2% for symptoms experience. As mentioned previously, self-rated 
health is a valid and well-comparable question used in many studies (e.g. Office for National 
Statistics 2002, Rimpelä et al. 2004, Emerson et al. 2006, Johnson and Wang 2008, National 
Institute for Health and Welfare 2012). To obtain more comparable results particularly about 
the prevalence of long-term diseases the question could have been formulated in a similar 
way as in the earlier Finnish studies (Arinen et al. 1998, Rimpelä et al. 2004). It would also 
have been possible to ask the parent to report if the child has a reimbursement number for 
some long-term disease(s) by the Social Insurance Institution. If medicine use for long-term 
diseases were the focus of research then the sample should have been taken from children 
having specific long-term diseases. However, the aim of this study was to explore the use 
of medicines among children in general. The question of long-term diseases was open-
ended, but for the symptoms experience, a list of symptoms was given with the possibility 
to report also other symptoms not mentioned in the list. Such a list may give a higher 
proportion of children that were having some symptoms currently since it helps parents to 
report also symptoms that may not be very severe in nature.  
The main outcome measures of the use of self-medication were chosen based on the last 
population-based surveys in Finland in order to obtain comparable results and to minimize 
recall bias (Klaukka et al. 1990, Arinen et al. 1998). The proportions of missing cases were 
low for the questions of self-medication, 2.2% for OTC medicines use and 1.8% for CAMs 
use. The questionnaire was addressed to the parent who mainly takes care of the child’s 
medication; the mother was typically the one who answered the questionnaire. It cannot be 
known if there is a proportion of children who have taken self-medication by themselves. 
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The reported OTC medicines (including registered vitamins) were coded according to 
ATC codes, but there was no official classification that could had been used for the CAMs 
reported. CAMs were coded mainly based on their content (e.g. probiotics, fish oils and fatty 
acids), but some CAMs were classified according to their purpose of use (e.g. products for 
constipation and stomach function). Products that could have been used for several 
purposes were difficult to classify. However, since the prevalences of most of the CAMs 
classified were quite low, they were combined under the class “other CAMs” in the final 
analysis. The most common classes, fish oils and fatty acids, and probiotics, were analysed 
as their own groups. Homeopathics were also selected as their own group for the analysis 
so that a cultural comparison of the use could be considered with other studies abroad.  
The results were also analysed by using multivariate logistic regression model, adjusted 
with confounding factors, which increase the reliability of the results. The discriminating 
ability of the logistic regression models were also reassured in the studies I, III and IV with 
receiver operating characteristic (ROC) curve analysis which showed the discriminating 
ability of the models to be mainly good for different variables. 
This survey may be considered to have been successful with regard to response rate, valid 
measurements that were used and the low proportions of missing cases in single questions. 
The results can be considered as representative, with regard to age and gender, of children 
under 12 years of age in Finland. 
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9 Conclusions  
1. The overall health among Finnish children is good. Over half of the children had 
experienced some symptom(s), mainly of common cold and eczema. One tenth had 
some long-term disease or had experienced some psychosomatic symptom. Allergy 
and asthma were the most common long-term diseases, while sleep disturbances and 
fatigue or dizziness were the most common psychosomatic symptoms. 
2. Half of the children had used some self-medication; approximately one fifth of the 
children had used some OTC medicine and one tenth some CAM. Analgesics and 
antipyretics, including NSAIDs, especially paracetamol, were the most common OTC 
medicines, and fish oils and probiotics the most common CAMs used.  
3. Parental socioeconomic background was not associated with health or the use of self-
medication among Finnish children.  
4. Parental attitudes have an impact on the use of self-medication among children, 
especially CAM use. Parents who were worried about the risks of medicines were 
more likely to medicate their child with CAMs. 
9.1 SUGGESTIONS FOR FURTHER STUDIES  
Based on this study, the following suggestions for further studies can be made: 
 
1. Up-to-date information should be obtained about the self-care process among 
children: detection of symptoms, evaluation of symptoms and the action applied for 
the treatment of symptoms. 
2. It should be explored how parents perceive the use of OTC medicines compared to 
CAMs in treating children’s self-limiting conditions.  
3. It should be identified how parents administer OTC medicines and/or CAMs when 
treating their child’s symptoms. 
4. Further studies are needed about parental socioeconomic background with regard to 
children’s health and the use of medicines at different ages. 
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Hyvä lapsen äiti tai isä 
    
 
Tutkimme alle 12-vuotiaiden lasten lääkkeiden käyttöä ja siihen liittyviä ongelmia. Haluamme myös 
selvittää vanhempien ajatuksia lasten lääkehoidosta. Tutkimuksemme tukee tammikuussa 2007 
voimaantulleen lastenlääkeasetuksen tavoitteita: saada lasten käyttöön tutkittuja, turvallisia ja 
tehokkaita lääkkeitä. 
 
Lapsesi on yksi satunnaisesti tähän tutkimukseen valitusta 6000 alle 12-vuotiaasta suomalaislapsesta. 
Hänen nimensä ja sinun yhteystietosi on saatu väestörekisterikeskuksen (PL 7, 00521 Helsinki) 
väestötietojärjestelmästä.  Lapsen nimi on valmiiksi painettu kyselylomakkeeseen. Vastauksesi on 
tärkeä ja arvokas, vaikka lapsella ei olisi käytössään yhtään lääkettä. 
 
Toivomme, että kyselyyn vastaa aikuinen, joka yleensä huolehtii lapsen lääkkeiden käytöstä. 
Voit halutessasi pyytää lasta vastaamaan kysymyksiin kanssasi, esimerkiksi kertomaan kokemistaan 
oireista.  
 
Vastaaminen on täysin vapaaehtoista. Täytettyäsi lomakkeen, palauta se oheisessa kuoressa 
16.2.2007 mennessä. Postimaksu on valmiiksi maksettu. Antamiasi tietoja käsitellään ehdottoman 
luottamuksellisesti. Kyselylomakkeessa on numero palautettujen lomakkeiden kirjanpitoa varten. Tällä 
tavoin yritämme välttää lähettämästä muistutusta jo kertaalleen vastanneille.  
 
Vastaamalla kyselyyn annat arvokasta tietoa, josta on hyötyä lasten lääkehoitojen kehittämistyötä 
tekeville terveydenhuollon ammattilaisille ja sitä kautta kaikille lääkehoitoa saaville lapsille. 
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University of Kuopio 
Department of Social Pharmacy 
CHILDREN’S MEDICINE USE 
 
Answer the questions by circling the best fitting alternative or writing down in the blank space. Your answers are 
important even if the child is not using any medicines.  
 
 
 
 
1. The child is a 
1 Girl 
2 Boy 
 
2. Date of birth 
 day     month  year 
 
3. Is the child  
1 The firstborn 
2 The second born 
3 The third born 
4 Other. Which one? ______________ 
 
4. Which answer best describes the child’s usual care during 
the day? (choose the one which they spend the most hours at 
per week) 
1 Goes to school or preschool  
2 Is taken care of by a child minder outside home  
3 Is in the day-care-centre 
4 Is taken care of at home alone or with brothers and sisters 
5 Some other way. How? ____________________________ 
 
 
 
 
5. What is your opinion about the health status of the child at 
the moment?  
1 Good 
2 Fairly good 
3 Moderate 
4 Fairly poor 
5 Poor 
 
6. Does the child have any illness or injury that has been 
diagnosed by a doctor? 
1 No 
2 Yes. What illness / illnesses? 
 _____________________________________________
 _____________________________________________  
 
 
 
 
 
7. Below is a list of symptoms. Circle for each symptom if the child is suffering it at the moment. 
 
Symptoms No Yes Don’t know 
    
Constipation 1 2 3 
Diarrhoea 1 2 3 
Stomach bug 1 2 3 
Flatulence/Wind 1 2 3 
Other stomach disorders, describe?___________________ 1 2 3 
Headache 1 2 3 
Pain in the neck or shoulders 1 2 3 
Pain in the lower back 1 2 3 
Earache  1 2 3 
Sore throat 1 2 3 
Growing pains 1 2 3 
Other pain, describe? _____________________________ 1 2 3 
High temperature/Fever 1 2 3 
Symptoms of cold/flu (e.g. runny nose,  cough) 1 2 3 
Allergic symptoms (e.g. runny nose, eye symptoms) 1 2 3 
Eczema or skin symptoms 1 2 3 
Fatigue or feeling faint 1 2 3 
Sleep disturbance 1 2 3 
Tension or nervousness 1 2 3 
Low spirit or depression 1 2 3 
Some other symptom, describe? _____________________ 1 2 3 
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8. Is the child using any prescription medicines at the moment? 
1 No (move to the question number 9) 
2 Yes. List every medicine and its purpose of use. List also 
 those medicines that are used as needed. You can 
 continue on the last page. 
 
Name of the medicine 
(e.g. Beclomet Easyhaler®) 
 Purpose of use  
(e.g. asthma) 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
9. Has your child taken yesterday or the day before yesterday 
any Over the counter (OTC)  medicines, including vitamins? 
1 No (move to the question number 10) 
2 Yes. List every medicine and its purpose of use. 
 
Name of the medicine 
(e.g. Pantyson®) 
 Purpose of use  
(e.g. skin rash) 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
10. Is the child using any OTC medicines or vitamins daily or 
almost daily? 
1 No (move to the question number 11) 
2 Yes. List all the medicines that are used daily or almost 
daily, and also how long the child has been using them. 
 
Name of the product 
 
 How long has (s)he been  
using it? /Length of use 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
  
 
 
 
 
 
 
 
 
11. Has the child taken yesterday or the day before yesterday 
any medicinal herbs, botanicals, or homeopathic products? 
1 No (move to the question number 12) 
2 Yes. List all products and their purpose of use. 
 
Product  Purpose of use 
 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
12. Has any medicine caused the child harm? 
1 No (move to the question number 13) 
2 Yes. List all the harms and medicines that have caused 
them. You can continue on the last page. 
 
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________ 
 
13. Have there been any other problems with the child’s 
medication? 
1 No (move to the question number 14) 
2 Yes. What kind of problems? List also which medicines 
have caused them. You can continue on the last page. 
 
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________
_____________________________________________________ 
 
14. At what age, on your opinion, can the child decide on 
taking a medicine for little ailments, e.g., headache, 
independently without any control or guidance of a parent?
  
1 < 4 
2 4–5 
3 6–7 
4 8–9 
5 10–11 
6 12–13 
7 14–15 
8 16–17 
9 18 or older 
10 No opinion 
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15. Below is a list of information sources. Circle for every source how much you have used it when searching information  
concerning children's medication.  
 
Source of information Much To some extent Little Not at all 
     
Doctor/Physician 3 2 1 0 
Nurse 3 2 1 0 
Public health nurse / School health nurse 3 2 1 0 
Relative or friend who is a health care professional 3 2 1 0 
Pharmacist 3 2 1 0 
Helpline, which one?___________________________ 3 2 1 0 
Patient information leaflet 3 2 1 0 
Brochures concerning medicines 3 2 1 0 
Medical books 3 2 1 0 
Some other book, which one? ____________________ 3 2 1 0 
Health journals 3 2 1 0 
Ordinary newspapers or magazines 3 2 1 0 
Radio, television 3 2 1 0 
The internet, which websites?_____________________ 3 2 1 0 
Family, friends 3 2 1 0 
Health food shop /Natural product store 3 2 1 0 
Other, what?__________________________________ 3 2 1 0 
     
 
 
16. How reliable do you find the following information sources when searching information concerning children's medication?  
 
 
Source of information 
Very  
reliable 
 
Reliable 
Quite  
reliable 
Not  
reliable 
No 
opinion or 
haven’t used 
      
Doctor/Physician 4 3 2 1 0 
Nurse 4 3 2 1 0 
Public health nurse / School health nurse 4 3 2 1 0 
Relative or friend who is a health care professional 4 3 2 1 0 
Pharmacist 4 3 2 1 0 
Helpline, which one?___________________________ 4 3 2 1 0 
Patient information leaflet 4 3 2 1 0 
Brochures concerning medicines 4 3 2 1 0 
Medical books 4 3 2 1 0 
Some other book, which one? ____________________ 4 3 2 1 0 
Health journals 4 3 2 1 0 
Ordinary newspapers or magazines 4 3 2 1 0 
Radio, television 4 3 2 1 0 
The internet, which website?_____________________ 4 3 2 1 0 
Family, friends 4 3 2 1 0 
Health food shop /Natural product store 4 3 2 1 0 
Other, what?_________________________________ 4 3 2 1 0 
      
INFORMATION SOURCES OF MEDICINES 
3 (6) 
 
 
 
17. Who is the person that filled in this questionnaire? 
1 Mother 
2 Father 
3 Other. Who?__________________________________ 
 
 
18. What is your own mother tongue? 
1 Finnish 
2 Swedish 
3 Other. What?_________________________________ 
 
19. Number of children in the family _____________________ 
 
 
20. Your year of birth ___________ 
 
 
21. Did the child take part in filling in this questionnaire? 
1 No 
2 Yes 
 
 
22. Have you taken any degree in health care? 
1 No 
2 Yes. Which one? 
_____________________________________________ 
 
23. Which province do you live in? 
1 Lapland  
2 Oulu 
3 Eastern Finland  
4 Western Finland  
5 Southern Finland  
6 Åland 
 
 
24. What is your level of education? Circle the highest degree 
you have taken. 
1 Primary school  
2 School certificate (equivalent to year ten) 
3 Higher School Certificate (leaving certificate/year 12) 
4 Non University Diploma 
5 Bachelors Degree (University)  
6 Postgraduate University Degree 
 
 
25. What is your current employment status? (Choose the one 
best option that describes your situation) 
1 I’m working part-time/full time 
2 I study or go to school  
3 I’m a housewife/-husband  
4 I’m temporarily absent from work (for example on 
maternity leave) 
5 I’m on sick leave  
6 I have been laid off or I’m unemployed  
7 I’m retired 
 
26. How much is your household’s net income (the income 
after taxes) in its entirety? If you don´t know it exactly you can 
mark your estimate of it. 
1 Below 500 e 
2 500–999 e 
3 1000–1499 e 
4 1500–1999 e 
5 2000–2499 e 
6 2500–2999 e 
7 3000–3999 e 
8 4000–4999 e 
9 5000–7499 e 
10 7500–10000 e 
11 Over 10 000 e 
 
 
27. Are you yourself using any prescription medicines at the 
moment? 
1 No (move to the question no 28) 
2 Yes. List all the medicines that you are using and their 
purpose of use. 
 
Medicine 
(e.g. Femoden®) 
 Purpose of use 
(e.g. contraception) 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
   
 
 
28. Have you taken yesterday or the day before yesterday any 
Over the counter (OTC) medicines, including vitamins? 
1 No (move to the question no 29) 
2 Yes. List the name of the medicine and what you used it 
for. 
 
Medicine  
(e.g. Burana®) 
 Purpose of use 
(e.g. headache) 
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29. Have you taken yesterday or the day before yesterday any medicinal herbs, botanicals, or homeopathics?  
1 No (move to the question no 30) 
2 Yes. List the name of the product and what you used it for. 
 
Product  Purpose of use 
 
 
 
  
 
 
  
 
 
  
 
 
30. Below is a list of statements. Circle the option nearest to your own opinion.  
 
Statement I agree 
completely 
I agree I don’t agree 
or disagree 
I disagree I disagree 
completely 
No 
opinion 
       
Medicines are necessary in treating illnesses. 5 4 3 2 1 0 
Side-effects of children’s medicines worry me. 5 4 3 2 1 0 
I try to avoid giving medicines to my child. 5 4 3 2 1 0 
Over the counter (OTC) medicines are safe. 5 4 3 2 1 0 
Fever, a natural means of defense of the child’s body, 
should not be lowered artificially with medicines. 
5 4 3 2 1 0 
The child needs to learn how to bear the pain. 5 4 3 2 1 0 
Prescription medicines are effective. 5 4 3 2 1 0 
I usually give less analgesic to the child than is 
recommended in the instructions. 
5 4 3 2 1 0 
Prescription medicines are safe. 5 4 3 2 1 0 
Medicines can disturb the body’s own capability to heal 
illnesses. 
5 4 3 2 1 0 
Medicines that a doctor has prescribed for the child are 
necessary. 
5 4 3 2 1 0 
Medicines are unnatural to the human body. 5 4 3 2 1 0 
I try to take care of my child’s ailments by some other means 
than using medicines. 
5 4 3 2 1 0 
The more you need to use analgesics the less effective they 
are for pain. 
5 4 3 2 1 0 
I take care of my child’s minor ailments by using OTC 
medicines. 
5 4 3 2 1 0 
Medicines are dangerous, even when used according to the 
instructions. 
5 4 3 2 1 0 
I take my child to see a doctor only when other ways of 
treatment do not help. 
5 4 3 2 1 0 
Long-term use of analgesics reduces the pain threshold. 5 4 3 2 1 0 
OTC medicines are effective. 5 4 3 2 1 0 
Doctors prescribe antibiotics to children too easily. 5 4 3 2 1 0 
Interactions of medicines worry me. 5 4 3 2 1 0 
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Itsehoito on yleinen tapa hoitaa 
lasten lieviä oireita. Suomessa lasten 
itsehoidon yleisyyttä on viimeksi 
tutkittu vuonna 1995/96 osana laa-
jempaa väestötutkimusta suoma-
laisten terveydestä ja terveyspalve-
lujen käytöstä. Tämän tutkimuksen 
tavoitteena oli tutkia millainen on 
suomalaisten lasten terveydentila, 
kuinka yleistä itsehoidon käyttö on 
lapsilla ja mitkä tekijät niihin ovat 
yhteydessä. Tutkimuksen aineistona 
käytettiin vuonna 2007 toteutettua 
väestötutkimusta alle 12-vuotiaiden 
lasten lääkkeiden käytöstä.
